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Cervicocerebral artery dissection (CeAD) is one of the leading causes of ischemic stroke 
in the young and middle-aged adults. Although the outcome is good in many CeAD 
patients, the socioeconomic consequences of stroke at young age may be remarkable. The 
knowledge about dissections is constantly growing, but most studies are based on small 
patient series. 
 
Dissection is defined as a tear in the vessel wall, which may lead either to stenosis or 
occlusion of the artery via formation of a thrombus within the arterial wall, or to formation 
of a pseudoaneurysm. Most dissections occur in extracranial cervical arteries. Intracranial 
CeADs may lead to subarachnoid hemorrhage, and they have commonly been regarded a 
contraindication for anticoagulation, a common treatment for extracranial CeAD. 
 
The pathophysiology of CeAD is poorly understood. CeAD patients probably have a 
constitutional, partly genetic weakness of the vessel wall, which predisposes to tears in the 
connective tissue within the vascular wall in occurrence of environmental triggers of the 
disease, such as acute infection, migraine, or minor trauma.  
 
For this thesis project, we collected a register of all consecutive CeAD patients treated at 
the Helsinki University Central Hospital, Finland, between 1994 and 2008. In the first part 
of the thesis, we studied 103 patients with intracranial artery dissections (IAD). IADs 
could be divided into 2 distinct groups: i) non-aneurysmatic IADs presenting without 
subarachnoid hemorrhage that are associated with favorable outcomes and safe 
anticoagulant therapy, and ii) aneurysmatic IADs, characterized by subarachnoid 
hemorrhage and poorer prognosis.  
 
Secondly, we evaluated characteristics, prognostic factors and vascular risk factors in 301 
CeAD patients. We found association of CeAD with male sex, and possible association 
with smoking and migraine, especially migraine with aura. Stroke severity and recent 
infection were associated with poorer outcome. 
 
The three other publications for the thesis were part of the CADISP project (Cervical 
Artery Dissection and Ischemic Stroke Patients), an international consortium focusing on 
research on CeAD. Its aims are to perform a genetic association study and clinical studies 
especially on risk factors, stroke-preventive treatment, and outcome predictors. For the 
clinical part of CADISP, 983 patients with CeAD, 658 patients with ischemic stroke due 
to causes other than dissection, and 1170 healthy control subjects were included in 8 
countries and 18 centers. Our center contributed with 175 CeAD patients (18% of all 
CeAD patients), 168 ischemic strokes due to other causes (26%), and 269 healthy control 
subjects. 
 
In the CADISP cohort, vascular risk factors were less frequent in CeAD patients 
compared with young patients with a non-CeAD ischemic stroke. In comparison with 
healthy controls, hypercholesterolemia, obesity, and overweight were less frequent in 
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CeAD patients, whereas CeAD patients had more hypertension. This suggests that 
hypertension may be a risk factor for CeAD. 
 
Finally, migraine was more common in CeAD patients with stroke than in patients with 
ischemic stroke due to a cause other than CeAD. We detected no excess of ischemic 
strokes, specific arterial distribution or other clinical or prognostic features characteristic 










































Kaula- ja aivovaltimodissektoitumien riskitekijät ja taudinkuva 
 
Kaula- ja aivovaltimodissektoituma on yleisimpiä aivoinfarktin aiheuttajia nuorilla ja 
keski-ikäisillä potilailla. Vaikka suurin osa sairastuneista toipuu hyvin, saattaa aivoinfarkti 
nuorella iällä aiheuttaa merkittävää ja pitkäaikaista haittaa. Dissektoitumia koskeva 
tutkimustieto lisääntyy jatkuvasti, mutta taudin harvinaisuuden vuoksi suurin osa 
julkaisuista on perustunut pieniin potilasmääriin. 
 
Dissektoitumassa valtimon seinämään tulee repeämä, mikä voi johtaa verihyytymän 
kehittymiseen suonen seinämän sisään ja suonen ahtautumiseen tai tukokseen, tai 
pseudoaneurysman muodostumiseen. Kaula- ja aivovaltimodissektoituma sijaitsee yleensä 
kaulan alueen valtimoissa kallonulkoisesti, ja sen hoidossa käytetään yleisesti 
verenohennuslääkkeitä. Kallonsisäistä dissektoitumaa on pidetty vasta-aiheena 
verenohennuslääkkeille lisääntyneen lukinkalvonalaisen vuodon riskin takia. 
 
Kaula- ja aivovaltimodissektoituman patofysiologia tunnetaan puutteellisesti. Potilailla 
ajatellaan olevan altistava valtimoseinämän sidekudoksen rakenteellinen heikkous, 
mahdollisesti geneettisistä syistä. Heikko seinämä on alttiimpi repeämälle, jonka laukaisee 
jokin tilapäinen tekijä kuten akuutti tulehdustauti, migreeni tai vähäpätöinen vamma. 
 
Väitöskirjan kaksi ensimmäistä osatyötä perustuu Helsingin ja Uudenmaan 
sairaanhoitopiirin alueella vuosien 1994-2008 välisenä aikana hoidetuista kaula- ja 
aivovaltimodissektoitumapotilaista kerättyyn rekisteriin. Ensimmäisessä osatyössä oli 
mukana 103 kallonsisäisen dissektoituman sairastanutta potilasta. Nämä dissektoitumat 
jakaantuivat kahteen eri ryhmään: i) ei-aneurysmaattisiin kallonsisäisiin dissektoitumiin, 
jotka eivät johtaneet lukinkalvonalaiseen vuotoon, joiden ennuste oli hyvä, ja joiden 
hoidossa verenohennuslääkkeet olivat turvallisia. ii) Lukinkalvonalaiseen vuotoon 
johtaneisiin dissektoitumiin, joilla oli huono ennuste.  
 
Toisessa osatyössä käsiteltiin kaula- ja aivovaltimodissektoitumapotilaiden taudinkuvaa, 
ennustetekijöitä ja riskitekijöitä 301 suomalaisen potilaan aineistossa. Enemmistö 
potilaista oli miehiä, ja dissektoitumapotilailla tupakointi ja migreeni, erityisesti aurallinen 
migreeni, olivat yleisiä. Vakava aivoinfarkti ja viimeaikaiset tulehdustaudit liittyivät 
huonompaan ennusteeseen. 
 
Kolme muuta osatyötä ovat osa CADISP-projektia (Cervical Artery Dissection and 
Ischemic Stroke Patients). Tämän kansainvälisen kaulavaltimodissektoitumien 
tutkimukseen keskittyvän hankkeen tavoitteet ovat selvittää taudin geneettisiä ja muita 
riskitekijöitä, sen hoitoa ja ennustetekijöitä. CADISP-hankkeen kliiniseen osaan osallistui 
8 maasta yhteensä 18 keskuksesta 983 kaulavaltimodissektoitumapotilasta (joita Helsingin 
alueelta oli 175), 658 aivoinfarktiverrokkia joilla infarkti johtui muusta syystä kuin 
dissektoitumasta (n=168), ja 1170 tervettä henkilöä (n=269).  
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CADISP-aineistossa vaskulaarisia riskitekijöitä oli kaulavaltimodissektoitumapotilailla 
vähemmän kuin aivoinfarktin muusta syystä sairastaneilla verrokeilla. Terveisiin 
verrokkeihin nähden dissektoitumapotilailla oli vähemmän hyperkolesterolemiaa ja 
ylipainoa, mutta useammin korkea verenpaine. Hypertensio saattaakin olla kaula- ja 
aivovaltimodissektoituman riskitekijä. 
 
Viidennessä osatyössä todettiin migreenin olevan yleisempää aivoinfarktin saaneilla 
kaulavaltimodissektoitumapotilailla kuin muusta syystä aivoinfarktin saaneilla verrokeilla. 
Migreeniä sairastavat kaulavaltimodissektoitumapotilaat eivät eronneet migreeniä 


































1   INTRODUCTION 
 
Stroke occurs unexpectedly, all of a sudden, but the consequences to the individuals are 
long-lasting, even life-long. The socio-economic burden is remarkable, especially in the 
young and middle-aged patients. Cervicocerebral artery dissection (CeAD) leads to stroke 
in about 3/4 of the cases, and is the most frequent single etiology of ischemic stroke in 
patients under 50 years of age 1. CeADs can be divided into two subgroups: i) traumatic 
dissections caused by severe direct, blunt trauma, and ii) spontaneous dissections that 
occur without preceding events or after minor trauma, although in some cases, this 
classification may be arbitrary. This thesis focuses on spontaneous CeAD in internal 
carotid arteries (ICA) and vertebral arteries (VA).  
 
The first publications on non-traumatic CeAD date back to the 50’s 2 3, when the disease 
was regarded as a rarity. Until the 1980s, most cases were diagnosed post-mortem, which 
led to a publication bias towards the most severe forms of the disease. Since then, 
development and accessibility of vascular imaging methods and better awareness of CeAD 
among physicians have enabled diagnosis of dissection in patients with stroke, transient 
ischemic attack (TIA), or very mild symptoms. 
 
Several factors are associated with cervicocerebral artery dissections, such as connective 
tissue diseases, minor trauma, recent infections, smoking, and migraine, but the 
pathophysiology of CeAD is incompletely understood. It is hypothesized that, at least in 
part of the patients, an underlying genetic defect of the vessel wall predisposes to 
dissection, triggered by environmental factors. To provide data on CeAD in Finnish 
patients, we established a register of all consecutive CeAD patients. Due to low frequency 
of CeAD, collaboration between several stroke centers is essential to study genetic and 
environmental risk factors, as well as outcome and treatment aspects of the disease. 
CADISP project (Cervical Artery Dissection and Ischemic Stroke Patients) was set up to 


















2   REVIEW OF THE LITERATURE 
 
 
2.1 Definition and pathology 
 
Cervicocerebral arteries consist of three layers: i) tunica intima (internal layer with 
endothelium), ii) tunica media (muscular middle layer), and iii) tunica adventitia (external 
layer consisting of connective tissue). Cervicocerebral artery dissection is defined as an 
intramural hematoma within the arterial wall in subintimal, medial, or subadventitial 
layers. There are two suggested mechanisms for this process: i) Dissection begins with a 
tear in the inner, intimal layer. This is supported by a recent study 4 where a third of 
dissected vessels showed an intimal flap in high-resolution magnetic resonance imaging 
(MRI). ii) The intramural hematoma is originated by a rupture of the vasa vasorum – 
nutrient blood vessels - inside the vessel wall without intimal tear 5. In either case, the 
resulting intramural hematoma propagates within the layers, subsequently creating a false 
lumen next to the real lumen (Figure 1). The false and true lumens may reconnect distally. 
The inner surface of the arterial wall, separating the true and false lumens, is called an 















A: common carotid artery 
B: external carotid artery 
C: internal carotid artery 
D: tunica adventitia 
E: tunica media 
F: tunica intima 
G: ruptured intima 
H: intramural hematoma, false 
lumen 
I: true lumen 
It is hypothesized that the plane of dissection (location in the inner or outer arterial layers) 
relates to the clinical and radiological picture of CeAD 6 7. If the splitting of the vessel 
wall is situated in the medial (middle) or subintimal layers, the inward expanding 
intramural hematoma narrows the true lumen of the artery or even totally blocks distal 
blood flow. Both the mechanical barrier and coagulation processes activated by the 
rupture may induce brain ischemia, which occurs in about 4/5 of the patients 8 9. The 
ischemia can be embolic due to dissection-site thrombosis, which is most common in 
extracranial artery dissections (EAD) 10-12, or of hemodynamic origin, more often seen in 
intracranial dissections (IAD) 13. The degree of stenosis does not seem to relate to 
occurrence or number of cerebral diffusion-weighted imaging stroke lesions, but the 
infarctions may be larger in occlusion 14. This is in line with occlusive CeAD leading to 
more severe strokes 15. 
 
A subadventitial dissection may lead to an aneurysmal dilatation of the artery wall. The 
layers and surrounding tissues of extracranial arteries are strong, preventing the outermost 
surface of the artery from rupturing. The aneurysmal CeADs seldom lead to ischemic 
stroke, and there is evidence that patients with dissecting aneurysms have the best 
outcome 16. Intracranial arteries have no external elastic membrane between the adventitia 
and the media, have a thinner adventitia, and less elastic fibers in the media, so that the 
adventitial and muscular layers are only about 2/3 thick compared to extracranial arteries 
17 18, and the internal elastic lamina is the strongest of the layers 19. Thus, intracranial 
subadventitial dissections may more often lead to subarachnoid hemorrhage (SAH) 20, 
discussed in chapters 2.2 and 2.5.3. 
 
 
2.2 Cervicocerebral dissections in extra- and intracranial arteries 
 
Arterial dissections may occur in any artery of the body. However, the cervical arteries are 
dissected more frequently than other arteries of the same size, such as the coronary or 
renal arteries 5. This can be explained by the exposure to tearing and rotational forces 
during head movements, as well as compression against the bony structures of the cervical 
vertebrae. It was suggested that the styloid process may cause mechanical injury to ICA 
since patients with ICA dissections (ICAD) had longer styloid processes than ischemic 
stroke controls 21. ICA and VA are anchored at their origins from the common carotid and 
subclavian arteries, and distally where ICA enters into the carotid canal, and VA 
penetrates the intervertebral foramina at its V2 portion and through the dura 7. The 
portions of the arteries between these structures are freely mobile. Dissections occur most 
often extracranially, at the sites of greatest mobility: ICAD in the cervical part starting 
about 2 cm distal to the carotid bulb, and continuing up to the skull base 22, and VA 
dissections (VAD) from the level of C1 vertebra to C2 23, C6 24, or Th1 25 vertebrae.  
 
The characteristics of intracranial artery dissections are less well defined than those in 
EADs. Most of the data come from non-European studies. IAD is currently regarded as a 
different entity with possibly different etiologic and genetic background 26. IADs seem to 
occur at younger age than EADs 27, and the proportion of IADs of all CeADs is thus 
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higher in children than in adults 28 29. IADs are located mostly in vertebral and basilar 
arteries in adults 30, and in anterior circulation in children and adolescents 31. There are 
many studies on intracranial dissecting aneurysms in vertebral arteries 32 33 as they may 
account for 3 to 7% of SAH cases 19 34 and 28 % of posterior circulation aneurysms 33. 
Reports on unruptured IADs – presenting with aneurysms, stenoses, occlusions, and 
double lumens at imaging - are rarer. Oka et al. 27 presented 6 original cases and a review 
of additional 39 patients treated for IS due to intracranial ICAD during years 1980-2004. 
The mean age of these 45 patients was 21.4 years, but also children were included, which 
is not usual in many studies on EADs performed in centers of adult neurology, and various 
studies may not be fully comparable. Two Japanese studies report long-term follow-up of 
intracranial VAD. The mean age for 11 patients in the paper of Yoshimoto et al. 35 was 
47.3 years, and 7 (64%) were men. Of the dissections, 4 were fusiform or saccular 
aneurysms and the rest presented with stenosis, occlusion, or double lumen. Nagagawa et 
al. 36 had a series of 17 patients (mean age 55.2, 76% men), 5 of which had aneurysms. 
 
Manabe et al. 30 found IAD in 14 out of 373 consecutive non-emergency outpatients, all 
having vertebrobasilar dissections. In this patient cohort, CeAD was not initially 
suspected, and patients were admitted to the neurological and neurosurgical departments 
due to a variety of symptoms (headache in 46%, focal neurological deficits, dizziness, gait 
disturbances). Occurrence of IAD was not significantly higher among the headache group 
(4.7%) than the non-headache group (3.0%). These findings indicate that IADs that do not 
lead to ischemic or hemorrhagic lesions are more common than previously thought.  
 
Dissections originating extracranially may also extend intracranially. The extent of this 
phenomenon varies greatly between different publications, and many studies report 
dissections that are only either extracranial or intracranial. The dural fibers perforate 
subadventitial and medial layers of VA at dural crossing 37, and ICA at proximal and distal 
dural rings 38, anchoring these arteries tightly. This prevents many extracranial dissections 
from extending intracranially and minimizes mobility of intracranial vessels. However, 
intracranial and intracranially extending dissections (here referred to as “combined 
dissections”, CD) may be more frequent than previously thought. In a German study with 
250 patients with stroke or TIA from 30 departments of neurology 15, 6.8 % of patients 
had CD. This was more common in ICAD than in VAD (12.3 vs. 0.9%). Pure IADs 
(n=36) were excluded from this study. In a small patient series from the USA 39, 20% of 
dissections were intracranial and 20% combined in 20 patients. A Taiwanese study 40, 
comprising 73 consecutive CeAD patients in a single center, reported intracranial 
involvement in 38% (9/24) of anterior circulation dissections, and in 82 % (40/49) of 
posterior CeADs. Pure IADs were found in 3/24 (12.5%) in anterior circulation and in 
27/49 (55%) in posterior circulation dissections.  
 
Reported dissections are mostly single (72-90%) 41 42. Multiple dissections occur usually 
in two vessels – in the same type of artery (ICA or VA) bilaterally, or less often one in 
ICA and the other in VA. Triple and quadruple dissections constituted 1.6% of all CeADs 
in a series of 740 consecutive CeAD patients 43.  
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2.3 Epidemiology of cervicocerebral artery dissections 
 
In the past, cervicocerebral artery dissection was considered a rare cause of stroke. The 
significant development in diagnostic methods has improved recognition of CeAD as the 
leading etiology of ischemic stroke in the young and middle-aged adults. Digital 
subtraction angiography (DSA) was developed in the late 1970s by Charles Mistretta, and 
the first magnetic resonance angiography (MRA) was performed in 1985 44. In the 1980’s, 
CeAD was reported in about 10% (4 to 22%) of ischemic strokes (IS) in this age group 45-
47, and since the late 1990’s, the proportion has been around 15 to 20%, depending on the 
upper age limit, population, and the extent of vascular imaging used 1 48-51.  
 
In the elderly, traditional risk factors for stroke such as hypertension, diabetes, peripheral 
artery disease, and atrial fibrillation are more common. The traditional stroke etiologies, 
large artery atherosclerosis, cardioembolism, and small vessel disease thus predominate in 
this age group 52 and simultaneously number of dissections decreases 53. Since most 
ischemic strokes (IS) affect older age groups 54, dissections are found in only 2-3% of all 
IS 55 56. In a large database of over 3 000 000 US stroke patients with or without 
thrombolysis, only 0.3% of all patients with IS had CeAD 57. 
 
Most of the reports on the incidence of CeAD refer to ICAD only. Moreover, only a few 
population-based studies on CeAD exist. A French report with ICA dissections from years 
1987 to 1993 56 found a rate of 2.9 per 100 000 (95% confidence interval, CI, 1 9-3 9), 
similar to 2.6 per 100 000 from the United States with ICAD occurring between 1986 and 
1992 58. Both studies date to the era when underdiagnostics of CeAD was common, and 
the numbers of included dissections were small (36 and 10, respectively). Internal carotid 
dissections outnumber those diagnosed in vertebral arteries. The VAD/ICAD ratio in three 
hospital-based studies in the 1990’s 59-61 was in average 0.33 (0.23 to 0.64), which led to 
an estimated incidence of VAD to be 1 to 1.5 per 100 000 5. Since that the ratio has 
slightly increased to an average of 0.53 (0.44 to 0.79) in more recent studies on CeAD 
from Western countries 8 62-64. Lee et al. 63 also noticed an increase in the incidence rate of 
VAD from 0.54 per 100 000 during the first half of their study period to 1.52 during the 
latest years. As they suggested, this difference most likely reflects better diagnostics of 
VAD by MRA. In their study, however, the overall incidence of CeAD was only 3.01 
(95% CI 2.05 to 3.97). It can thus be concluded that at least 1/3 of dissections occur in 
vertebral arteries, and the overall incidence of CeAD treated in hospitals could be around 
3.5 to 5 per 100 000. Male preponderance has been reported in many studies 64 65. 
 
However, it is likely that a significant number of CeAD still remain underdiagnosed. 
Patients with no or very mild symptoms may not seek medical help or are misdiagnosed as 
having migraine, inexplicable transient dizziness or post-traumatic muscular pain, for 
example, whereas extensive diagnostics in the patients with severe stroke is not always 
regarded necessary, particularly among the oldest individuals or those with apparently 
poor prognostics. Moreover, in regions with several neurological units serving the same 
population, establishment of comprehensive registries of CeAD patients requires 
collaboration between the units. 
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CeAD affects all age groups from early childhood to elderly, with a slightly increased risk 
in the fifth decade of life. The reported mean ages have been very similar in different 
studies; 44.0 in a large French cohort 8; 45.3 among French and Swiss patients 65; 45.8 in a 
population-based study from the United States 63, and 46.8 in an Italian study 9. Women 
are a few years younger than men at the time of the dissection, with mean age 43.6 to 47.5 
in men, and 39.6 to 44 in women in recent studies 39 61 64-66. Although CeAD occurs in 
children 28 29 67, it can be expected that as the amount of risk factors for CeAD increase 
with aging, the incidence of CeAD increases towards adulthood. Such factors may include 
sporting activities, hypertension, and pubertal hormonal changes. In a study comparing 
stroke subtypes in children (<15 years and 15 to 18 years of age) and young adults (>18 to 
45 years) from Indiana, United States 68, all cervicocerebral artery dissections in children 
(n=3) occurred in teenagers (15 to 18 years). There is evidence that skeletal abnormalities 
may contribute to CeAD in children 69. 
 
Patients with internal carotid artery dissections are slightly older than those with 
vertebrobasilar dissections. In the study of Lee et al. 63, ICAD occurred on average at 47.0 
years, VAD at 43.4 years. Arnold et al. 65 reported the mean age of ICAD as 43.0 in 
women, 48.5 in men, whereas these figures were 40.8 for women and 44.4 for men in 
VAD. 
 
The characteristics of CeAD seem to be slightly different in non-Caucasian populations. In 
the Asian countries, VAD is more common, and dissections occur more often in 
intracranial arteries 30 40. These differences contribute to a greater incidence of 
subarachnoid hemorrhage (SAH) in Asian patients (chapter 2.5.3). In a Mexican study 51, 
VAD (n=72) also exceeded the number of ICAD (n=58), and the patients were younger 
(mean age 35.4) than in most of the other studies published on CeAD. These features may 
be due to true ethnic difference with respect to genes, environmental factors, life style or 






Cervicocerebral dissection appears to be a multifactorial disease. The current theory on 
pathogenesis of CeAD, shared by many researchers 42, suggests that a structural defect 
weakens the arterial wall and predisposes it to a tear, which is triggered by environmental 
factors. The defect may be genetic, at least in part of the patients, and/or due to transient 
arteriopathy. Factors that may increase arterial wall vulnerability, predisposing to 
spontaneous CeAD, are recent infection, hypertension, hyperhomocysteinemia, and 	  
migraine 42. In addition to dissections due to severe cervical trauma (non-spontaneous 






2.4.1 Genetic risk factors 
 
There are several points suggesting that at least part of CeAD susceptibility is explained 
by genetic factors with a possible relationship with connective tissue abnormalities. 
Firstly, risk of CeAD may be elevated in some monogenic connective tissue diseases 
(CTD). Patient series on vascular Ehlers Danlos syndrome (vEDS) found history of CeAD 
in 2 to 6% of patients 71 72,  but the association of CeAD with Marfan syndrome, Loeys-
Dietz syndrome, and osteogenesis imperfecta or other monogenic disorders such as 
autosomal-dominant polycystic kidney disease, alpha-1 antitrypsin deficiency 26, and 
Williams syndrome 73 is less clear. However, only a minority of all CeAD patients have a 
diagnosed CTD 26. Secondly, alterations in dermal connective tissue with autosomal-
dominant heritance are found in half of CeAD patients 42. They resemble those seen in 
monogenic CTDs but are less dramatic. This indicates the possibility that a mild form of a 
known CTD or a yet unknown CTD could underlie CeAD, or that there are several genetic 
polymorphisms, each having a minor influence on the properties of connective tissue 74. 
Thirdly, familial CeADs have also been described 74, constituting no more than 0 to 3% of 
all CeADs 26. Due to CeAD underdiagnostics in the last century, these numbers are 
expected to increase in the future. Some patients also have family members with 
dissections in other arteries than cervical (e.g. intracranial, renal, and aorta) 75. Finally, 
CeAD has been associated with concomitant arterial changes, such as aortic root 
dilatation, fibromuscular dysplasia, arterial wall hyperdistensibility, and  impairment of 
endothelium-dependent vasodilatation 26. 
 
Screening for genetic abnormalities in CeAD patients with no known CTD by candidate 
gene or linkage studies have not yielded notable or consistent results. The genetic studies 
may have been underpowered due to small patient numbers; only 4 of the 16 genetic 
association studies on CeAD so far had >100 patients 26 76. The most promising of the 
results were associations of CeAD with methylenetetrahydrofolate reductase (MTHFR) 
677TT genotype and intercellular adhesion molecule 1 (ICAM-1) E469K polymorphism 
26, but the latter has not been replicated. Three studies (two of which overlap), found the 
MTHFR 677TT genotype to be more frequent among CeAD patients, but there are also 
reports suggesting that there is no association 26 76. In a recent report 77, novel mutations in 
the transforming growth factor β receptor 2 (TGFβR2), were found in 2 (3.6%) patients. 
Mutations in TGFβR 1 and 2 are also related to Loeys-Dietz syndrome and thoracic aortal 




The association between migraine and ischemic stroke has been recognized for some time, 
and is most likely multifactorial 78. These conditions share common characteristics such as 
neurological deficits, headache, and cerebral blood flow changes, and there may also be a 
causal relationship 79. According to a recent meta-analysis, migraine with aura (MA), not 
migraine without aura (MO), is associated with IS 80. Migraineurs have a two-fold risk for 
stroke compared to those without migraine, and the association is clearest among young 
individuals, women, and patients with less vascular risk factors 78.  
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One of the many links between migraine and stroke could be CeAD. Both migraine and 
CeAD occur predominantly in young and middle-aged adults. Migraine is more common 
among women and women with CeAD are younger than men (see Chapter 2.3). A number 
of studies have found high frequencies of migraine among CeAD patients 63 65 81-87. Silbert 
et al. 88 reported migraine rates similar to the general population 88, but this study lacked a 
control group. Whether CeAD is related to MA or MO or both, is not clear. The studies on 
the topic have mostly had small patient numbers and heterogeneous control groups: i.e. 
healthy controls from hospital staff 82 84, spouses and friends 87 or random selection from 
population 86, and part of the control subjects were ischemic stroke patients 81 82 84. Most of 
the studies used the International Headache Society criteria of migraine 89, but there were 
some methodological differences between studies. For example, in the study of Pezzini et 
al. 82, patients with both MO and MA were included in both groups (as MO and MA 
patients) thus increasing the frequency of MO, whereas Artto et al. 86, considered aura as a 
“dominant” feature, and the patients with both MO and MA were included only in the MA 
group. In addition, the confounding factors used in multivariate regression models were 
inconsistent. 
 
Compared to healthy controls, the frequencies of both MA and MO seem to be increased 
in CeAD. In a French study with 47 CeAD patients and 52 controls 81, a history of 
migraine was reported in 49 % of CeAD patients and in 21 % of healthy controls (odds 
ratio, OR, 3.6;	  95%	  CI	  1.5-­‐8.6,	  p=0.005). This was mostly due to MO (OR 3.2, 95% 1.2-
9.0; p=0.025), but since there were only 6 CeAD patients and 4 healthy controls with MA 
(OR 1.7; p=0.45), no firm conclusions can be drawn on MA. Migraine was associated 
with CeAD also in an Italian study 82 with 72 CeAD patients: migraine history was 
positive in 59.7 % of the patients, compared to 30.6 % in 72 non-CeAD IS patients and 
18.1 % in 72 healthy controls (OR 3.14; 95% CI 1.41–7.01, and OR 7.41; 95% CI 3.11–
17.64 for the comparisons, respectively). The frequencies of MA were, again, low: 6 
CeAD, 9 non-CeAD IS patients, and 6 healthy controls had MA. In comparison to the 
percentage of CeAD patients with MA of all migraineurs in these two studies (26 and 
14%), the study of Silbert et al. 88 reported 43 % of the migraineurs to have MA. 
In a more recent Italian study 84, partly overlapping with the previous one 82, with 106 
CeAD and 227 non-CeAD IS patients and 187 healthy controls, both MO and MA were 
associated with CeAD (OR 5.45 95% CI 3.03–9.79 for MO; and OR 4.06, 95% CI 1.63–
10.2 for MA compared to healthy controls). MO, not MA, was more frequent in the CeAD 
group compared to the non-CeAD IS patients. Artto et al. 86 reported that MA was more 
common in 313 CeAD patients than in 313 healthy controls (OR 2.41, 95% CI 1.53–3.80), 
and that the association of MO and CeAD was parallel, but did not reach statistical 
significance (OR 1.64, 95% CI 0.98–2.76).  
A meta-analysis on studies in English language comparing migraine in CeAD patients and 
healthy controls is presented in Figure 2. The meta-analysis was performed using 
unadjusted ORs with Review Manager (RevMan), Version 5.1. Copenhagen: The Nordic 
Cochrane Centre, The Cochrane Collaboration, 2011. Since the two Italian studies overlap 
82 84, only the latter was used in the comparisons. Migraine was more common among 
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CeAD patients compared to healthy controls (Figure 2a). In a subgroup analysis, both MO 
(OR 2.25, 95% CI 1.04-4.88) and MA (OR 2.21 [1.52-3.21]) were more frequent among 
CeAD patients (data not shown). Similarly, migraine was more common among CeAD 
patients compared to non-CeAD IS group (Figure 2b). However, this was due to MO only 
(for MO: OR 4.28 [2.66-6.88]; for MA: OR 1.99 [0.68-5.89], data not shown). This shows 
that healthy individuals and non-CeAD IS patients differ as referents.  In a recent meta-
analysis these two kind of control groups were combined 85, and the difference in MA 
between CeAD patients and all referents did not reach statistical significance (OR 1.50 
[0.76-2.96]). 
 
Figure 2. Studies on migraine in CeAD patients vs. controls 
 




b) Migraine in CeAD vs. non-CeAD IS patients 
 
 




In addition to the high prevalence of migraine among CeAD patients, some findings 
support the hypothesis that migraine and CeAD may have causal relationship – and/or 
perhaps share common pathogenic mechanisms. Levels of elastases – enzymes that 
degrade elastic fibers in extracellular matrix, thus weakening the vessel wall – have been 
found to be elevated in patients with migraine 90, especially in patients with MA. 
Endothelium-dependent vasodilatation is impaired in both CeAD and migraine patients, 
suggesting that there may be a common generalized vascular disorder predisposing to both 
conditions 82. Another link between migraine and CeAD may be patent foramen ovale 
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(PFO), although the association is speculative with few supporting data. Its association 
with stroke and migraine has been under debate in recent years. It can be hypothesized that 
paradoxical microscopic emboli that, especially during Valsalva-provoking activities, 
travel to posterior circulation via PFO and cause visual migraine auras 91. In a recent study 
of 981 young stroke patients 92, migraine with aura was associated with an interatrial right-
to-left shunt. In a Swedish study 50, PFO was found in 5 of the 7 patients with probable or 
possible arterial dissection. However, Swiss investigators 93 assumed PFO and CeAD to 
be different diseases by comparing findings of cerebral ischemia with diffusion-weighted 
imaging in patients with CeAD and PFO. The lesions caused by CeAD were more often 
large, multiple and territorial, whereas PFO led more often to single, non-territorial 
infarcts.  
 
There are several interesting findings about migraine in CeAD patients. As in general 
populations, also among CeAD patients women have more migraine than men 65. 
Migraine was more common among VAD patients that did not develop brain ischemia 
than among those with stroke in one study 94. However, there were only 21 patients in the 
non-ischemic group. Migraineurs tend to develop headache or neck or facial pain 
associated with dissection more often than the non-migraineurs 95. In a North-American 
series of 177 CeAD patients, only 13% of those with previous headaches, mostly 
migraine, did not have headache as a presenting symptom of CeAD 62. One explanation 
for this association could be sensitization of migraineurs for pain 96, amplifying the painful 
stimulus caused by dissection. Migraine characteristics were different between CeAD and 
non-CeAD IS groups in the study of Tzourio et al. 81: in CeAD patients, the age of onset 
of migraine was higher and there were more attacks during the past 3 months. The OR for 
migraine was higher for patients with multiple dissections (6.7; 95% CI 1.9-24.1; 
p=0.002) compared to non-CeAD IS than for single CeAD (OR 2.9; 95% CI 1.1-7.6; 
p=0.037) 81. Moreover, the prevalence of CeAD patients with both migraine and the 
TT677 MTHFR genotype was higher among patients with multiple dissections (3/16; 
18.8%) compared to those with single-vessel CeAD (12/90; 13.3%) and healthy controls 
(5/187; 2.7%, p=0.0008) 84. There is some evidence that migraine may alleviate or resolve 
after CeAD; this happened among 8/29 (28%) CeAD patients with migraine 88. 
 
2.4.3 Infection and inflammation 
 
Infections have been suggested as a predisposing factor for the arterial wall damage in 
CeAD. Guillon et al. 97 reported more infections (31.9%) in 47 CeAD patients compared 
to 52 non-CeAD IS controls (13.5%, p=0.032; OR 3.0; 95% CI, 1.1 to 8.2) during 4 weeks 
before the onset of symptoms. Recent infections were most common in patients with 
multiple dissections (50%; OR 6.4; 95% CI 1.7 to 24.0). Infection had no association with 
ischemic manifestations in CeAD 97. Grau et al. found as many as 58.1% infections during 
the preceding week in CeAD patients and 32.8% in non-CeAD IS patients (p=0.01) 98, and 
the association was not related to mechanical factors in infectious diseases (cough, 
vomiting). CeAD patients have also been reported to have higher plasma levels of high-
sensitivity C-reactive protein (CRP) in the convalescence phase (>9 months after CeAD), 
independent from vascular risk factors 99. This was thought to reflect long-standing 
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inflammatory mechanisms and not acute reaction to stroke, which usually does not last 
longer than 3 months 99. In another study, 18 patients with spontaneous CeAD had more 
often leukocytosis and elevated CRP in the acute phase compared with 25 traumatic (both 
minor and major trauma were included) CeAD patients 100. Patients with a subsequent 
clinical infection were excluded. In a German study, a generalized inflammatory 
arteriopathy, seen with high-resolution MRI and positron emission tomography, and 
lasting for 6 months, was seen in a quarter of CeAD patients 101. This was related 
particularly to the patients with >2 CeADs, which supports the finding of Guillon et al. 97 
of infections being related to multiple dissections. A French study demonstrated that 
periarterial edema, recent infection, and elevated CRP were more common in spontaneous 
than traumatic ICAD using high-resolution MRI 102. 
 
Infections may predispose to CeAD via indirect inflammatory and immunological 
mechanisms, where cytokines and proteases could weaken the arterial wall by inducing 
extracellular matrix degradation 97. This may cause a transient inflammatory arteriopathy, 
increasing the risk of multiple dissections 101. The individual inflammatory response may 
depend on genetic variability, which is consistent with the excess of ICAM-1 E469K 
polymorphism in CeAD patients 103. It can thus be concluded that inflammatory or genetic 
mechanisms may underlie the generalized arteriopathy in CeAD. This kind of arteriopathy 
was seen in superficial temporal artery biopsies of CeAD patients, taken during the first 
weeks after dissection 104.  
 
2.4.4 Vascular risk factors 
 
CeAD is presumably a non-atherosclerotic disease, and patients have been thought to have 
very few vascular risk factors 42, particularly compared with non-CeAD IS controls. 
According to a systematic review of the risk factors for the disease, CeAD patients have 
less hypertension, hypercholesterolemia, diabetes, smoking, and coronary artery disease 
than non-CeAD IS patients 105. Two studies have been designed for comparing CeAD 
patients and healthy controls in this aspect 6 106. According to the study of Arnold et al. 106, 
there were no differences in the prevalence of hypertension, diabetes mellitus (DM), 
hypercholesterolemia, and current smoking between 119 CeAD patients and 263 healthy 
controls, but body mass index (BMI) was lower in CeAD patients.  
 
Hypertension has been associated with CeAD compared to healthy controls in a few 
studies 6 103 107. In an Italian study 6 of 153 CeAD patients, and as many non-CeAD IS 
patients and healthy controls, hypertension was more frequent in CeAD patients presented 
with stroke vs. healthy controls, whereas the rates of hypercholesterolemia, current 
smoking, and DM were similar. This suggests that patients with hypertension might have 
increased risk for stroke when CeAD occurs. In a rather small study with two cohorts of 
German CeAD patients (31 and 65 patients), hypertension was reported in 22% of all 
CeAD patients together and 6% of the healthy controls 103. Another German study of the 
same size (95 CeAD patients and 95 healthy controls) 107 about the association of 
homocysteine with CeAD reported higher blood pressure values in CeAD patients 
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(p=0.016), but there was no statistical difference in history of hypertension between CeAD 
patients (28%) and healthy controls (15%, OR 2.056, p=0.082).  
 
Hyperhomocysteinemia has been associated with cardiovascular diseases, although 
treatment with vitamins B6, B12, or folic acid has not reduced the risk of arterial ischemic 
events 108. CeAD patients were reported of having increased levels of homocysteine 105 in 
two studies, and the MTHFR C677T polymorphism was associated with homocysteine 
levels 107. Post-methionine load homocysteinemia was described in a patient with CeAD 
109. MTHFR catalyzes the homocysteine re-methylation to methionine 108. These findings 
are in keeping with the MTHFR C677T polymorphism being related with CeAD (see 
Chapters 2.4.1 and 2.4.2) and to the various mechanisms of homocysteine: it thickens 
vessel wall, increases matrix metalloproteinase activity, and enhances thrombus formation 




According to a common belief, mild mechanical traumas to cervical vessels may trigger 
CeAD. They include hyperextension, rotation, or lateroversion of the neck 42 such as 
sports activities 110, sneezing, coughing or vomiting, carrying heavy objects, whiplash 
injury, prolonged sustained head rotation, intercourse, and child delivery 42 111. However, 
these traumas are often non-dramatic and common, can occur every day to anyone, similar 
traumas lead to CeAD usually only once, and they are not consistently defined across 
studies. Nevertheless, several studies report traumas to be common among CeAD patients 
with frequencies from 12 to 34% 105. The frequency of various traumas was assessed in a 
systematic interview comparing CeAD and non-CeAD IS patients in the acute phase 112. 
The number of patients was quite small (47 CeAD patients), but the sum of all mechanical 
factors (e.g. heavy lifting, sexual intercourse, mild direct neck trauma, sports activities 
during 24 hours before first symptoms, and cervical manipulative therapy in the past 30 
days) was slightly increased in the CeAD group. It is not known whether cervical 
manipulation causes arterial damage or whether patients seek for manipulative therapy 
because of neck- or headache that is caused by CeAD. Smith et al. 113 reported spinal 
manipulative therapy to be associated with CeAD also after controlling for preceding pain, 




2.5 Clinical features of cervicocerebral artery dissections 
 
2.5.1 Local manifestations 
 
Local symptoms of CeAD can occur separately or in combination with ischemia and are 
often ipsilateral to dissection. They include pain in neck, face, ear or eye, headache, 
Horner’s syndrome (without anhidrosis), tinnitus, neck swelling, and cranial nerve 
dysfunction 42 88 114 115. Headache is a common presentation, and reported in 45-71% of all 
CeAD patients 9 55 62 64 65 and even more (82%) in VAD 116. Neck pain occurs in 25-58% 62 
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64 65. In a study of 20 patients with pain as the only symptom of CeAD 117, headache was 
mostly different from previous headaches, intense, and more often throbbing than blunt. 
The onset of pain ranged from very sudden (reaching maximum in 1 minute) to 
progressive (>24 hours). Neck pain was usually constrictive and less intense 117. Pulsatile 
tinnitus is related to the proximity of the damaged ICA to the tympanic membrane 7. 
Tinnitus has been reported in 5-11% 62 64 65 116, cranial nerve palsies, mostly in lower 
cranial nerves, in 5-13% of patients 65 114, and Horner’s syndrome in 29-37% of ICAD 
patients 9 64. Horner’s syndrome may occur also in VAD 114, but instead of being a sign of 
vessel wall rupture as in ICAD (due to peripheral interruption of sympathetic nerve supply 
to the eye), it is caused by brain stem ischemia. 
 
2.5.2 Ischemic manifestations 
 
Local symptoms may precede ischemia by minutes or days 5, they may begin 
simultaneously or ischemia may be the only symptom. Among 42 consecutive extracranial 
ICAD patients with stroke 118, 9 (21%) had no previous local symptoms. For the 
remaining 33 patients, the time interval between local signs and ischemia was less than a 
week for 82%. Ischemic symptoms due to CeAD – cerebral infarction, TIA, and rarely 
retinal ischemia or isolated ischemia of the spinal cord - are similar to those seen in 
strokes caused by other etiologies 42. Ischemic symptoms in ICAD lead to contralateral 
limb dysfunction or neglect, for example, and in VAD to nausea, vertigo, Horner’s 
syndrome, ataxia, and dysphagia. Also visual disturbances such as diplopia, blurred 
vision, and visual field abnormalities, resembling migraine aura, have been described 119.  
 
The frequency of ischemic stroke in diagnosed patients is around 50-70%. Stroke was 
reported in 51% of 76 Italian patients, and TIA in 17% 120. In 136 German patients 64, 
stroke occurred in 71% in ICAD and 85% in VAD, and TIA in 13% and 11%, 
respectively. In a French-Swiss study of 186 first-ever unilateral VAD 94, 77% had stroke 
and 13% TIA, and those with ischemic symptoms were older, more often male and 
smokers. In a study of 181 Swiss patients with 200 ICADs 121, 116 (58%) of dissections 
led to ischemic stroke, 22 (11%) to TIA, and 7 (3.5%) to amaurosis fugax or retinal 
ischemia. Patients with ischemia had more often high-degree stenosis or occlusion and 
hypercholesterolemia, less Horner’s syndrome and cranial nerve palsies. However, it 
might be that the differences in the occurrence of Horner’s syndrome and cranial nerve 
palsies are in part due to recruitment bias, since young patients with ischemic symptoms 
are more likely to be diagnosed than those with minor symptoms, whereas patients with 
Horner’s syndrome are suspected to have CeAD more likely than those with neck pain 
only. Thus, the proportion of non-ischemic CeAD patients may be greater than reported 42.   
 
It was suggested that intracranial dissections lead to ischemia more often than EADs, and 
that the delay from the first transient symptoms (pain, Horner’s syndrome) to stroke could 
be shorter for IADs 122. In a series of 10 intracranial ICAD patients 122, there was symptom 
fluctuation in 5 patients during the first 2 weeks. This was in line with hypoperfusion 
being a common cause for ischemia in IADs. 
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2.5.3 Subarachnoid hemorrhage 
 
Dissecting aneurysms in intracranial arteries may rupture causing SAH. A common 
guideline is to avoid anticoagulation in intracranial and combined dissections 116. 
Dissecting aneurysms also have a higher risk of rebleeding than non-dissecting saccular 
aneurysms 33. The risk of SAH in dissecting aneurysms is higher in “entrance-only” –
lesions than in entry-exit –aneurysms with reconnection into the true lumen and less 
pressure against the outermost artery wall 123. The symptoms of SAH do not differ from 
those in non-CeAD SAH 13. 
 
Bleeding complication has been reported to be more frequent in VAD than in ICAD both 
in early 31 and recent publications 19. Mizutani et al. 19 reported SAH in 57% of 
intracranial VAD and in 39% of ICAD. In a Taiwanese single-center series of 73 extra- 
and intracranial CeAD patients 40, anterior circulation CeAD led most often to ischemia: 
19 patients out of 24 had ischemic stroke, 2 both ischemia and SAH. Posterior circulation 
CeAD patients had similar occurrence of ischemia and SAH (21/49 had ischemia, 22 
patients SAH, 1 had both). Since most SAH patients are treated in neurosurgical units, the 
reported bleeding frequencies in CeAD may be underestimated in patient populations from 
neurological units only. In two large series of CeAD patients treated in departments of 
neurology, SAH rate was around 1% 8 65. It should be noted that most studies on 
symptoms, clinical characteristics and outcome of CeAD describe the ischemic 
subpopulation of CeAD patients. 
 
 
2.6 Diagnosis of cervicocerebral artery dissections 
 
The radiological signs of dissection include long tapered or filiform stenosis, a dissecting 
aneurysm, intimal flap and double lumen, a tapered occlusion (in ICAD usually >2cm 
above carotid bifurcation) and intramural hematoma or wall thickening 42 124.  
 
2.6.1 Digital subtraction angiography 
 
The former golden standard DSA is performed currently only occasionally, mainly before 
performing endovascular procedures, because it is invasive and does not allow direct 
visualization of the arterial wall 42 114. The rate of neurologic complications is around 0.9-





Cervical ultrasound (US) is sometimes used as a screening tool on an emergency basis for 
patients with suspected CeAD. It may show stenosis or occlusion of the vessel, or more 
rarely hypoechogenic wall hematoma, false lumen, hyperechogenic flap or 
pseudoaneurysm 127. However, it is operator-dependent, not reliable in CeAD near the 
skull base, within the transverse foramina, and intracranial arteries 128, and its sensitivity 
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in diagnosing VAD 128 or CeAD with low-grade stenosis or local symptoms only 127 is 
low. In the study of Arnold et al. 127, 1/3 of the ICAD with isolated Horner’s syndrome 
remained false-negative in US examination. Dittrich et al. 129 found US to be negative in 
11/86 (12.8%) patients diagnosed subsequently with CeAD by computed tomography 
angiography (CTA) or MRA. Seven of these were followed-up with repetitive US, and in 
five, US remained normal. The diagnosis should always be confirmed by CTA or MRA 42 




Development of multidetector CT angiography has made CTA a useful tool in CeAD 
diagnostics 130. For the present, CTA or MRA are regarded as equally good in diagnosing 
CeAD 130, but they have some differences. CTA is an irradiative method but usually more 
easily available. Vertinsky et al. 124 compared multidetector CTA and MR imaging. 
CT/CTA visualized more often intimal flaps, pseudoaneurysms, and high-grade stenoses, 
and was considered to be a better method for VAD 124, which is often a diagnostic 
challenge 114, but MRI/MRA was superior in diagnosing ischemic complications 124. 
Atherosclerotic ICA may be difficult to distinguish from dissection with CTA, but Leclerc 
et al. 89 found an eccentric lumen at the upper portion of ICA in all 12 stenotic ICADs but 
in none of the 22 atherosclerotic controls, in whom the location of maximum stenosis was 
lower than in ICAD. 
 
2.6.4 Magnetic resonance imaging 
 
MRI combined with MRA is considered the best method for diagnosing the intramural 
hematoma in CeAD 42 114, if one keeps in mind the time interval of a couple of days in 
development of methemoglobin in the intramural hematoma 131. High-resolution MRI, a 
novel technology to visualize vessel wall, is able to distinguish intraluminal thrombus 
from intramural hematoma and may be even better in showing intimal flaps and wall 
thickening than CTA or routine MRI/MRA 4, and may become routine imaging procedure 
in the future. 
 
 




CeAD patients have received thrombolytic agents in the acute phase of cerebral ischemia, 
since CeAD diagnosis is seldom clear before initiation of thrombolysis 132. There are no 
randomized controlled trials on thrombolysis versus placebo in CeAD patients. A recent 
meta-analysis 132 gathered previous case reports and series published on CeAD 
thrombolysis. Rates of symptomatic intracranial hemorrhage (3.1%), overall mortality 
(8.1%), and outcome (41% had modified Rankin Scale 0-1) of 180 thrombolyzed CeAD 
patients were compared to data from the Safe Implementation of Thrombolysis in Stroke - 
International Stroke Thrombolysis Register (SITS-ISTR). There were no marked 
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differences in the safety or outcome between CeAD patients and other ischemic stroke 
patients in SITS-ISTR study.  
 
There is, however, some evidence that thrombolyzed CeAD patients have worse outcome 
than patients with other causes for IS. In a series of 48 Finnish thrombolyzed young stroke 
patients, CeAD was associated with unfavorable outcome 133. Admission NIHSS is a 
strong predictor of outcome, and median NIHSS in CeAD patients was 10.5 compared to 
7 in all thrombolyzed patients in this series 133. In a large US cohort of almost 48000 
thrombolyzed IS patients and nearly 3 million IS patients without thrombolysis, 
characteristics of those with CeAD were compared with the rest 57. There were 488 (1%) 
thrombolyzed CeAD patients and 7374 (0.2%) non-thrombolyzed CeAD patients with 
stroke. The odds for moderate to severe disability were approximately 3-fold in CeAD 
patients, in both thrombolyzed and non-thrombolyzed groups, also when adjusted for age, 
sex, and admission NIHSS. This may in part be due to flow-limiting mechanical barrier, 
intimal flap, and exposure of the thrombogenic subintima. Thrombolytic agents may be 
less effective in the resulting platelet-rich thromboembolism 57. 
 
2.7.2 Anticoagulation and antithrombotic medication 
 
CeAD patients usually receive anticoagulation or antithrombotic agents for the first 
months after diagnosis. The rationale is to prevent further ischemic events. There are no 
randomized controlled studies comparing the medications, and the indications for 
choosing anticoagulation or antithrombotic agents - mostly warfarin or aspirin - vary by 
country and district. This is why systematic meta-analyses are to be interpreted with 
caution. According to reviews that meta-analyze non-randomized studies comparing 
anticoagulants and antithrombotics, the rates of death or disability do not differ between 
patients receiving these treatments 134 135 so it is recommended to choose the medication 
on a case-to-case basis 42. However, in a recent non-randomized study that included 198 
German patients with a follow-up of about 2.5 years 15, IS recurrence was more frequent 
(16.7%) with antiplatelets than with anticoagulation (2.0%; HR 0.11; 95% CI 0.02-0.69; 
p=0.02). It should be noted that only patients with IS or TIA were studied, while the 
previous meta-analyses included also non-ischemic ICAD and VAD patients 135 or ICAD 
patients 134.  
 
An ongoing project tries to evaluate if randomization into anticoagulation and 
antithrombotic medication would be feasible 136 137. However, the frequency of post-CeAD 
ischemic events is low and acquiring firm results from a randomized trial would require 
large patient populations (n=2000-3000).  
 
Since most of the recanalizations occur during the first few months after CeAD (see 
Chapter 2.8.1), anticoagulation is usually used for six months, but there are no studies 
focusing on the optimal length of the medical treatment. In case of incomplete 




2.7.3 Treatment of intracranial dissections 
 
The long-term treatment of non-ruptured intracranial dissections is not established. In 
IADs, the mechanism of ischemia is more often hemodynamic than in EADs 13. Due to the 
risk of rupture and subsequent SAH, some authors have regarded anticoagulation 
contraindicated 13 or at least advice to perform a lumbar puncture before initiation of the 
treatment 116 138. In cases of progressive or persistent ischemic symptoms despite 
medication, operative methods are also an option 13 139. 
 
Oka et al. 27 presented 6 patients with intracranial ICAD of their own together with 39 
previous patients from studies published between 1980-2008. Anticoagulation was given 
to 14 patients of which one also had a surgical operation and one received antiplatelets as 
well, and antiplatelets were given to an additional 10 patients, of which outome data were 
provided for 7. Of these 21 patients, 13 had good recovery. No comparison of outcomes 
between patients treated with or without anticoagulation/antiplatelet medication can be 
made due to incomplete data. The patients in the study of Oka et al. 27 were divided into 3 
groups: A) single attack and severe outcome; B) single attack and mild to moderate 
outcome; and C) recurrent attack and various outcomes. For group A, outcome is poor 
regardless of treatment, and patients in group B do fine with conservative treatment. They 
performed superficial temporal artery - middle cerebral artery bypass surgery for 2 of their 
own patients, one of which recovered well. To differentiate group B and C patients, the 
authors recommended close clinical and radiological follow-up for the first 2 weeks, and 
consideration of early surgical management in case of any new symptoms or findings for 
the group C.  
 
Self-expanding stent placement appeared to be safe and effective in 8 patients with ICAD 
causing occlusion or critical stenosis and thus hemodynamic insufficiency 139. The 
dissection was traumatic in 4. Of the 8 ICADs, 3 were intracranial lesions with initial 
NIHSS 5-10 and 0-1 at discharge.  
 
Surgical or endovascular interventions are more commonly used in the aneurysmal forms 
of IAD 13. Ruptured aneurysms should be treated early by neurosurgical methods 140. The 
indications for choosing conservative or operative treatment for patients with unruptured 
aneurysms are not clear. Naito et al. 141 recommended endovascular management for VAD 
if the aneurysm is large or growing. Therefore, careful follow-up with repetitive 
angiography at about 3 weeks is advisable 36 140. The options for surgical or endovascular 
treatments include proximal occlusion and trapping with or without bypass, coil 
embolization, stenting, and stenting with coil 13 32 140. It should be noted that because the 
aneurysm wall in CeAD does not include all the vessel wall layers, it may be weak. Many 
dissecting aneurysms are wide-necked or fusiform, which limits the use of aneurysmal 










Recanalization occurs most often by the first 6 months. It is seen more often in stenotic 
(48-77%) than in occlusive (35-44%) or aneurysmal (13-25%) CeAD 62 63 142. In the study 
of Schwartz et al. 62, partial recanalization was seen in 2 weeks, whereas total or near-total 
recanalization took in average 4.7 months. Baracchini et al. 120 investigated 74 CeAD 
patients with neurovascular US daily while at hospital, monthly after discharge and every 
6 months thereafter. Complete or hemodynamically significant (stenosis <50%) 
recanalization occurred in 72% of ICAD and in 65% of VAD. In this study, the 
recanalization rates between stenotic and occlusive CeAD did not differ statistically 
significantly. Recanalization has not been independently associated with outcome in most 
studies 142 143. In a Mexican population of 72 VAD and 56 ICAD patients 51, those with 
recanalized VAD had a better prognosis (OR 3.2, 95% CI 1.1–8.8; p=0.02). However, the 
results were not adjusted for age, sex, or baseline NIHSS. Moreover, the patient 
population may differ from European series: ICAD patients were markedly disabled at 6 
months: only 27% had modified Rankin Scale (mRS) 0-2.  
 
2.8.2 Neurological outcome 
 
Outcome in ischemic CeAD is generally good and depends mostly on the severity of 
initial stroke, as in strokes due to other etiologies 144. The mortality rate in CeAD is low 
(<5%) according to recent series 42. It is, however, likely that some CeAD patients with 
severe strokes and subsequent death remain undiagnosed, as well as many with oligo- or 
asymptomatic CeAD. Occlusion due to ICAD leads to worse prognosis compared to 
patients with atherothrombotic stroke etiology 11. This may be due to lack of pre-existing 
collaterals in CeAD. Indeed, occlusive ICAD patients with ≥2 activated collaterals 
(ophthalmic artery, anterior or posterior communicating arteries seen in transcranial 
Doppler within 24 hours of symptom onset) had a better outcome than those with none or 
1 collateral in a recent study 143. The proportion of patients with good functional outcome 
– defined usually as mRS 0-2 at 3 months - is around 70-90% 63 144 145, and less among 
patients with ischemic stroke 146. A summary of studies published during the last 10 years 
on outcome in CeAD is presented in Table 1. 
 
Age-related factors were discussed in the CADISP study 147. Although young CeAD 
patients with stroke (<34 years) had more often excellent outcome than the oldest (>54 
years) ones (69 vs. 58% had mRS 0-1 at 3 months), the difference was not statistically 
significant in multivariable analysis adjusted with sex, prospective vs. retrospective 







Table 1. Studies on outcome in CeAD in English language, published 2002-2012 
 
Study † Year No of patients (%) Brain infarction (%) mRS 0-2 (%) at 3 months mRS 0-1 (%) at 3 months
Dziewas et al. (64) 2003 All 126 96 (76) NA 88 (70)
ICAD 78 (63) 55 (71) NA 54 (69)
VAD 46 (37) 39 (85) NA 32 (70)
Beletsky et al. (145) 2003 All 105/116* 78 (67) 93 (89) NA
ICAD 49 (42) 29 (59) NA NA
VAD 67 (58) 49 (73) NA NA
Cimini et al. (146) 2004 All 10 10 (100) 5 (50) 3 (30)
ICAD 8 (80) 8 (100) 3 (38) 1 (13)
VAD 2 (20) 2 (100) 2 (100) 2 (100)
Arauz et al. (51) 2006 All 130 6 (5) 72 (55) at 6 months NA
ICAD 58 (45) NA 16 (27) NA
VAD 72 (55) NA 56 (78) NA
Arnold et al. (65) 2006 All 383/696* 410 (59)** 282 (74) 215 (56)
ICAD 501 (75) NA NA NA
VAD 163 (25) NA NA NA
Lee et al. (63) 2006 All 48 27 (56) 44 (92) NA
ICAD 32 (67)‡ 13 (41) 29 (91) NA
VAD 18 (33)‡ 15 (83) 17 (94) NA
de Bray et al. 2007 All 103 66 (64) NA 72 (70) at 6 months
ICAD 68 (69) 41 (60) NA NA
VAD 30 (31) 25 (83) NA NA
Fischer et al. (148) 2009 All 108 79 (73) NA 71 (66)
ICAD 87 (82) NA NA 56 (65)
VAD 19 (18) NA NA 14 (74)
† Studies that include consecutive, non-selected non-SAH CeAD patients (ICAD and/or VAD)
CeAD: cervicocerebral artery dissection; mRS: modified Rankin Scale; NA: not assessed
*Follow-up data were not available for all patients. **Outcome was presented only for patients with stroke.
‡Number of dissections
J M de Bray, G Marc, V Pautot et al.  Fibromuscular Dysplasia May Herald Symptomatic Recurrence of Cervical Artery Dissection. 
    Cerebrovasc Dis 2007; 23(5-6):448-452.  
 
 
Practically all patients with local signs only have a favorable outcome measured by mRS, 
but some may suffer from prolonged pain 88. However, the quality of life measured by 
Stroke Specific Quality of Life Scale (SSQOL) was impaired also in patients with local 
signs only (p<0.038 compared to SSQOL before CeAD) and in those with excellent 
functional outcome (mRS 0-1; p=0.013) in 99 Swiss patients 148.  
 
The aneurysmal form of IAD, leading to SAH, is not a benign disease. High mortality 
rates have recently been reported, especially among conservatively treated patients. Of 24 
Japanese conservatively treated VAD SAH patients 149, 16 (67%) died. Outcome in SAH 
is related to rebleeding, which occurs in 24-71% 150.  In a Japanese series of 62 VAD SAH 
patients 150, rebleeding was more likely in dissections near PICA origin (46%) than more 
distal ones (21%) and if angiography revealed “stenosis and dilatation” or “lateral 
protrusion” –patterns. The authors recommended early surgical management when these 
signs are present. Only 4/22 (18%) of the patients with rebleeding had “good recovery” on 
Glasgow Outcome Scale compared to 58% of those without. Mortality was 21% among 
patients with an intervention, and 56% among conservatively treated subjects. 
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Prognosis of unruptured IAD presenting with stenosis or occlusion seems to be better than 
in aneurysmal IAD. Oka et al. presented a summary of reported cases of ischemic 
intracranial ICAD 27. In studies published in 1990 or before, death occurred in 10/12 
(83%) of ischemic intracranial ICAD patients, but only 7/33 (21%) were dead or severely 
disabled in later reports (1994-2008) 27 with a relatively benign outcome. In the review 
article of Oka et al., the largest series of intracranial ICAD patients by Chaves et al. 122 
presented 10 patients with 9 ischemic strokes and 1 TIA. All patients had excellent or 
good functional outcome at 3 months.  
 
According to the few studies on prognosis of non-aneurysmal intracranial VAD, 
unruptured intracranial VAD has a tendency to spontaneous healing. In 1994, Kitanaka et 
al. 151 followed-up five unruptured VAD patients with pearl and string sign. There were 
angiographic changes during the first months in all affected arteries. Every one recovered 
well. The authors also presented a review of 12 previous intracranial unruptured VADs, of 
which 4 were ischemic. They concluded that the best treatment option in ischemic 
intracranial VAD is conservative treatment without antithrombotics when there is 
improvement in angiography. Some years later, characteristics of 11 patients with 13 
intracranial VADs, 4 of which were aneurysms, were reported 35. Cases with initial SAH 
were excluded. During follow-up, 9 patients received antiplatelet drugs, 2 had no medical 
treatment. Out of the 13 VADs, 8 (62%) were spontaneously recanalized or progressed to 
complete occlusion. One patient was later on treated by intravascular coil embolization 
because of persistent aneurysmal dilatation. Good recovery was first achieved in all, but 
two had a mild recurrent ischemic event, and one patient died 1.5 years later of SAH, 




Most patients (around 70%) develop one single CeAD and no recurrent events 41. It seems 
that if the patient has more than one dissection during his/her life, it is more common for 
multiple CeAD to occur simultaneously or during the first months after the initial 
dissection than after a long time interval. Early recurrences could be due to a transient 
arteriopathy 101, and late recurrences due to longstanding connective tissue alterations 42. 
Multiple dissections (i.e. more than one CeAD at the time of the first CeAD diagnosis) 
have been reported in 10-28% of cases 41 42, usually around 15%. The recurrences tend to 
be oligo- or asymptomatic 41 and diagnosed more often if repetitive, frequent imaging is 
performed. According to a recent review 42, in studies published before 2008, new stroke 
or TIA after initial diagnosis has been reported in 0-11.9% during a mean follow-up 
period of 1.0 to 9.3 years. In studies until 2009, a recurrent CeAD was diagnosed in 0-
8.3% with a follow-up of 0.5 to 9.3 years 42, with an exception of 25% in the study by 
Dittrich et al. 41. They reported as many as 19% recurrences during the first 4 weeks, and 
6% during 5 to 7 months after the first event in 36 CeAD patients investigated with 
repetitive MR 41. Of these 9 recurrences, 4 occurred in more than one artery. Also in the 
study of Baracchini et al. 120, there were more recurrences than reported in previous 
studies: 20 (26%) during the hospital stay, and additional 2 at 3 and 12 months. 
Interestingly, the early recurrences occurred in initially unaffected arteries, whereas the 
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later recurrent symptoms were due to lesions in the same arteries as the initial CeAD. All 
6 patients with family history of CeAD had a recurrence.  
 
Less is known about recurrences in ischemic forms of IADs. Unusual for EADs, Oka et al. 
27 reported early aggravation of symptoms in half of their patients (3/6), which was due to 
propagation of the dissection. One of the three patients received anticoagulation before 
recurrent symptoms. Mizutani et al. 19 followed-up 190 patients with IAD for a mean of 
over 3 years. Of these, 93 were ischemic IADs. There were 18 (9.5%) recurrences of 
which 12 occurred within the first month. Majority (n=13) of the recurrences presented 
with headache only, and the rest with infarction (n=4) or SAH (n=1). 
 
Among 177 US CeAD patients 62, recurrent stroke was detected in 15 (8.5%) of cases, half 
of which during the first 2 weeks. Recurrent CeAD occurred in 2 (1.1%). Weimar et al. 15 
studied recurrent ischemic stroke after CeAD in 198 patients, which occurred in 5.2% at 
hospital before discharge, 11% during the first year, and in 14% during the first 3 years. In 
a US population of 69 extra- and/or intracranial CeAD patients 152, new TIA, ischemic 
stroke, or death was reported in 16% during hospital stay and an additional 12% after 
discharge within a year. CeAD patients had less recurrent strokes than young stroke 
patients of other etiologies in a French 48 and a Finnish series 153. This may be due to 





































To investigate the long-term prognosis of intracranial artery dissections and analyze 
whether anticoagulation treatment is safe in this patient subgroup (I). 
 
 
To study the clinical features of cervicocerebral artery dissection in a patient population 
from Southern Finland (II). 
 
 
To plan, prepare, and realize a multinational European project (CADISP) on cervical 
artery dissections to study several clinical features and genetics of this disease (III). 
 
 
To study the distributions of vascular risk factors in cervical artery dissection patients in 
comparison with 2 control groups: i) age- and sex -matched ischemic stroke patients with 
a cause other than dissection and ii) healthy control subjects (IV). 
 
 























4    PATIENTS AND METHODS 
 
 
This study consists of two parts. 1) The two first publications (I, II) were carried out at the 
Departments of Neurology (I, II) and Neurosurgery (I), Helsinki University Central 
Hospital, Helsinki, Finland. 2) Publications III, IV, and V are based on the international 
CADISP project (Cervical Artery Dissection and Ischemic Stroke Patients, 
www.cadisp.org). The Finnish patients in the CADISP study were treated in the 
Department of Neurology, Helsinki University Central Hospital, and they partly overlap 
with the patients in publications I and II.  
 
The study protocols were approved by relevant local authorities in all participating centers 
and were conducted according to the national rules concerning ethics committee approval 
and informed consents.  
 
 
4.1 Data collection 
 
A flow diagram of patient selection is presented in Figure 3. 
 
4.1.1 Finnish patients (I, II) 
 
The publications I and II are retrospective, descriptive, register-based studies. The 
Helsinki University Central Hospital serves as the only neurological emergency unit and a 
teaching hospital for a defined population of 1.5 million in Southern Finland. Potential 
candidates were identified using electronic search of the hospital’s databases for diagnoses 
related to CeAD, ischemic stroke, and SAH, and their medical records were reviewed. The 
patients living in the hospital catchment area and with the discharge diagnosis of CeAD 
were included.  
 
The diagnosis was made based on MRA, CTA or, rarely, DSA. For diagnosing intramural 
hematoma in CT-angiography, the following criteria were applied: The diameter of the 
artery was greater than in the contralateral side and proximally/distally to the dissection, 
and the residual lumen was eccentric in location relative to the surrounding hematoma. 
Radiological images were analyzed by neuroradiologists, and for patients in whom CeAD 
was considered possible, the images were re-analyzed. Uncertain cases were excluded. All 
patients included in the study had one or more of the typical diagnostic radiological 
findings: intramural hematoma, intimal flap or double lumen, dissecting aneurysm, long 
filiform stenosis, rat tail-shaped or flame-like occlusion, or an occlusion (if in ICA, >2cm 
above carotid bifurcation) that recanalized into a long filiform stenosis. Recanalization 
was defined as a radiologically normalized artery after stenosis, and as reperfusion after 
occlusion. The register of CeAD patients in Helsinki University Central Hospital area 
includes the following for each patient: age, sex, domicile town, brain vascular imaging 
results, putative risk factors, BMI, blood tests during hospital stay (On admission: 
complete blood count, blood glucose, electrolytes, renal and liver function tests, creatine 
 35 
kinase, cardiac enzymes, activated partial thromboplastin time, whether thromboplastin 
time or international normalized ratio; 24 to 72 hours after admission: lipid profile), 
several neurological scores including National Institutes of Health Stroke Scale (NIHSS), 
Glasgow Coma Scale, mRS, and Barthel Index were recorded on admission, discharge, 
and at 3 months. Repeat angiography was typically performed at 3-6 months. In case of 
residual stenosis or dissecting aneurysm, another angiography was performed at 12 
months. mRS 0–2 at 3 months was considered a favorable outcome, and mRS 0–1 an 
excellent outcome.  
 
Intracranial dissections (IAD) treated in the neurological unit were divided into two: A 
dissection located completely within the cranium was classified as “purely intracranial 
dissection,” (ID) and a dissection starting extracranially but extending intracranially as 
“combined dissection” (CD). For the first sub-study (I), only intracranial dissections (IDs 
and CDs) were included. These patients were called “non-SAH patients”. All cases of 
diagnosed CeAD treated at the Department of Neurology between January 1994 and 
October 2004 were reviewed. Out of 256 patients with CeAD, 81 had IAD. Immediately 
after CeAD diagnosis and exclusion of SAH with negative noncontrast brain CT or MRI 
scan, all patients received intravenous full-dose heparin sulfate, or subcutaneous low-
molecular-weight heparin. Within a few days, oral warfarin was initiated and continued 
for at least 3 months. Heparin was continued until warfarin treatment achieved target 
plasma levels (international normalized ratio, 2.0 to 3.0). The clinical features were 
presented separately for ID, CD, ICAD, and VAD.  
 
To ensure that all patients with IAD treated in the catchment area were recruited, we 
reviewed all medical records and images of patients hospitalized in the Department of 
Neurosurgery between August 1998 and October 2004 with the diagnosis of SAH. All 
IADs were included, also in other than carotid or vertebrobasilar arteries. The radiological 
findings in the patients matching the criteria (n=22) were typically fusiform aneurysm, 
double lumen, and/or intramural hematoma, or fusiform aneurysm with arterial wall 
irregularity together with no notable arteriosclerosis. Risk factors, clinical features and 
outcome were presented for SAH and non-SAH CeAD patients. 
 
For the second sub-study (II) we recruited all non-SAH CeAD cases treated at our 
neurological department at the Meilahti Hospital between January 1994 and August 2007, 
and all patients diagnosed at the two other neurological units of our hospital (Jorvi and 
Peijas Hospitals) between January 2000 and August 2007. We excluded patients (n=133) 
who i) lived outside the catchment area, ii) were treated as CeAD, but the radiological 
diagnosis could not be verified, or iii) had cervicocerebral artery dissection in other than 
internal carotid or vertebrobasilar arteries. In this study, intracranial and extracranial 
dissections were also analyzed separately. The patients were followed-up until the end of 
August 2008. The rates of vascular risk factors were compared to the prevalence of risk 
factors in the general Finnish population, obtained from Statistics Finland 




4.1.2 CADISP patients (III-V) 
 
The primary aim of the CADISP consortium was to perform a genetic association study to 
identify genetic susceptibility factors of CeAD. For this purpose, consecutive patients, 
aged ≥18 years by the time of enrolment, with internal carotid artery or vertebral artery 
dissections were recruited in 20 centers from 9 countries. To solve whether the genes 
possibly to be found are specific for CeAD, consecutive patients with ischemic stroke due 
to causes other than dissection (non-CeAD IS) were also recruited by the same centers. 
Non-CeAD IS patients were matched on sex and age with CeAD patients. All but 2 
centers (London, Munich) also participated in a clinical study including detailed screening 
of putative environmental risk factors and clinical and radiological characteristics. For 
each participant, a venous blood sample was collected, and a detailed standardized 
questionnaire was filled in by a stroke physician. The CADISP clinical study comprises 
983 CeAD and 658 non-CeAD IS patients recruited in 18 centers from 8 countries 
(Argentina, Belgium, Finland, France, Germany, Italy, Switzerland, and Turkey). Since 
substantial difference in genes, risk factors and life habits were to be expected between 
patients from different countries, the country of inclusion was taken into account in the 
statistics. 
 
Patients were recruited both prospectively and retrospectively. Those recruited 
retrospectively had the qualifying event before the beginning of the study in each center 
and were identified through local registries of CeAD patients. All eligible patients were 
invited to take part in the study. The great majority (>96%) of patients had a qualifying 
event between 1999 and 2009.  
 
Pure IADs and iatrogenic dissections were excluded from the CADISP study. CeAD 
patients had to present with a mural hematoma, aneurysmal dilatation, long tapering 
stenosis, intimal flap, double lumen, or occlusion >2 cm above the carotid bifurcation 
revealing an aneurysmal dilatation or a long tapering stenosis after recanalization. The 
non-CeAD IS patients had a recent IS confirmed on brain imaging, and MRA or CTA, 
performed within 7 days after the IS, were negative for CeAD; excluded were patients 
with iatrogenic IS, cardiopathies at very high embolic risk, arterial vasospasm after SAH, 
or autoimmune or monogenic disease possibly explaining the IS. 
 
One center (Helsinki) also collected healthy controls as part of the CADISP project, since 
Finnish referents for genetic analyses were lacking (see 4.3). These Finnish healthy 
controls (n=269) were recruited prospectively within the Helsinki area; most of them 
(n=233) were recruited randomly with the help of the Finnish Population Register Center; 
the rest were spouses of CADISP patients (n=17) and unrelated friends or hospital staff 
(n=19). Rest of the healthy controls that were used in sub-study IV but not in genetic 
analyses comprise a random selection from pre-existing population-based surveys for 
France, Belgium, and Italy (MOnitoring NationaL du rISque Artériel [MONA-LISA]-Lille 
study for northern France and Belgium, n=383; MONA-LISA-Strasbourg study for 
central-eastern France, n=309; and Vobarno study for northern Italy, n=209). See sub-
study IV for details. The Finnish and Italian healthy controls are individuals without a 
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history of vascular disease (peripheral artery disease, stroke, or myocardial infarction). 
The healthy controls were used in the sub-study IV, from which 293 CeAD and 102 non-
CEAD IS patients from Germany, Switzerland, Argentina, and Turkey were excluded 
because country-, sex-, and age-matched referents with detailed vascular risk factor data 




Figure 3. Patient selection into sub-studies I-V 
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HUCH: Helsinki University Central Hospital; CeAD: cervicocerebral artery dissection; ID: pure 
intracranial artery dissection; IS: ischemic stroke 
 
 
4.2 Variable definition 
 
The risk factors were defined as follows: Hypertension: antihypertensive treatment or 
blood pressure >140/90 mmHg during nonacute phase; Hypercholesterolemia: 
antidyslipidemic treatment or total cholesterol value >5.0 mmol/l, LDL >3, HDL < 1 or 
triglycerides >2 for sub-studies I and II, and total cholesterol ≥6.20 mmol/L or low-density 
lipoprotein cholesterol ≥4.1 mmol/L for sub-studies III-V, measured within 48 hours after 
admission to the hospital; Diabetes: antidiabetic treatment or fasting blood glucose ≥7 
mmol/l during non-acute phase. Hormonal therapy: use of oral contraceptives or 
postmenopausal substitution therapy at time of event. Smoking: Smokers were divided into 
current (smoking within a month) and past smokers. Previous infection: for sub-studies I 
and II, a history of respiratory or gastrointestinal tract infection within 1 month before 
admission. For sub-studies III-V, an infection in the week preceding the dissection with i) 
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at least 1 typical symptom of infection together with fever (temperature >38°C), or ii) at 
least 1 typical symptom of infection together with serologic, cultural, or radiologic 
findings indicating an acute infection, or iii) the combination of at least 2 typical 
corresponding symptoms 155. A recent trauma was a physical impact on the head or neck 
(e.g. extreme neck movements, cervical manipulation, lifting up heavy loads) <1 month 
before the first symptoms of CeAD. If the trauma led to a visit to a physician or 
hospitalization, it was considered major. Lifetime history of migraine was classified 
according to the International Headache Society criteria 89. 
 
 
4.3 Genetic analyses (III) 
 
The aim of the sub-study III was to present the strategy of the CADISP network. The 
majority of CADISP patients were included in both genetic and clinical parts. This thesis 
focuses on the clinical aspects of CADISP. The genetic analyses are described in more 
detail in the sub-study III. Briefly, we planned (III) and performed (Debette et al., 
submitted) a genome-wide association study (GWAS) where hundreds of thousands of 
single nucleotide polymorphisms (SNPs), distributed across the chromosomes, are 
genotyped. This approach does not require any hypothesis of the underlying 
pathophysiology beforehand. The genome-wide association analyses were performed at 
the Centre National de Genotypage, CNG (http://www.cng.fr/). In addition to the GWAS, 
we also selected SNPs for candidate genes, based on previous genetic studies on CeAD, 
vEDS, aortic aneurysms and dissections, and intracranial aneurysms (see Chapter 2.4.1 
and sub-study III). The genotype frequencies were primarily compared between CeAD 
patients and healthy controls. In a secondary analysis the significant findings were tested 
separately for non-CeAD IS patients, in order to confirm that the findings were specific 
for CeAD and did not reflect a more general susceptibility for ischemic stroke. The study 
setting also allowed us to search for interactions between polymorphisms and 
environmental factors or CeAD characteristics (i.e. risk factors, dissection site). A pre-
existing database of >14000 controls from CNG was used in the analyses, together with 





A two-tailed value of p<0.05 was considered statistically significant. The analyses were 
performed with a commercially available, statistical software package SPSS for Windows 
(I: version 12.0.1; II: version 14.0.1; V: PASW 18.0) and Statistical Analyses System 
software version 9.2 (SAS Institute, Cary, NC, sub-study IV). 
 
4.4.1 Sub-studies I, II 
 
Groupwise comparisons were made using T-test, Mann–Whitney U-test, Kruskal–Wallis 
H-test, chi-square, Fisher’s exact, and Newcombe–Wilson tests. Stratified analysis was 
performed when these tests were statistically significant to exclude potential confounders 
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(e.g. presence vs. absence of infarction/sex/ICAD vs. VAD/ IAD vs. EAD). In the sub-
study II, logistic regression was used to test whether the results in chi-square and stratified 
analyses remained statistically significant after controlling for potential confounders. The 
following comparisons with logistic regression were performed for this thesis: ID vs. CD; 
non-SAH vs. SAH patients; EAD vs. IAD; ICAD vs. VAD; mRS 0-1 vs. mRS 2-6 
(unpublished data). The thesis also contains some novel unpublished data on risk factors, 
symptoms, and outcome for sub-studies I and II (Tables 2-6). 
 
4.4.2 Sub-study IV 
 
We compared the prevalence of vascular risk factors between i) CeAD patients vs. healthy 
controls, ii) non-CeAD IS patients vs. healthy controls, and iii) CeAD vs. non-CeAD IS 
patients. The groups were compared using logistic regression models adjusted for age, sex, 
and country of inclusion. In secondary analyses, we tested whether associations with 
CeAD were maintained in the following CeAD subgroups comparing them to all referents: 
ICAD or VAD, presence or absence of cerebral ischemia, and retrospective or prospective 
recruitment. Because few referents <35 years of age were available, we performed 
sensitivity analyses including only individuals ≥35 years of age.  
 
4.4.3 Sub-study V 
 
All CADISP patients with migraine data available were included (CeAD: n=968; non-
CeAD IS: n=653). CeAD patients with or without migraine were compared. When 
comparing CeAD and non-CeAD IS patients, only CeAD patients presenting with 
ischemic stroke were included (CeADstroke, n=635). This way the groups differed in one 
aspect only (i.e. etiology of stroke). The groups (CeADstroke vs. non-CeAD IS; and CeAD 
patients with vs. without migraine) were compared by using chi-square, Mann-Whitney U, 
and T tests, and logistic regression, adjusted for the following possible confounding 
factors: age, sex, country of inclusion, and prospective/retrospective recruitment. CeAD 
and non-CeAD groups differ in terms of vascular risk factors (sub-study IV). Vascular risk 
factors were thus added as covariates to the comparisons regarding migraine and its 
subtypes. Since women have migraine more frequently than men 156, the analyses were 
performed separately for both sexes. A subgroup analysis of patients without patent 













5    RESULTS 
 
 
5.1 Prognosis and safety of anticoagulation in intracranial artery dissections 
(I) 
 
There were 81 non-SAH patients with either purely intracranial or combined dissection 
(Tables 2, 3). The majority of these were located in vertebrobasilar arteries (VAD: n=59, 
73%; ICAD: n=22, 27%). Patients with ID were a few years younger (ID 41.5 vs. CD 46.0 
years), although this difference was not statistically significant. The patients with purely 
intracranial ICAD were the youngest (mean age 34.0 years), and those with combined 
VAD were the oldest (47.4 years). Majority (n=76) received warfarin during the first 
months, and the rest used aspirin. No recurrences or new infarctions were detected 
clinically or radiologically during the first 3 months. None of our patients developed 
clinical or imaging signs of SAH. One patient died at the acute phase (day 3) due to severe 
brain infarction. Complete recanalization was observed in 31/43 (72.1%) of the initially 
stenosed arteries. Of the 34 initially occluded arteries, 7 (20.6%) recanalized totally and 10 
(29.4) partially. None of the occlusions in the ID group (n=8) recanalized totally. 
Recanalization was not a predictor of outcome. 
 
The patients with ID and CD were compared for this thesis using multivariable regression 
analyses (Table 2). There were no statistical differences between ID and CD regarding 
age, sex, location of dissection (ICAD/VAD), risk factors, occurrence of brain infarction 
or occlusion, admission NIHSS, symptoms, or outcome, although there was a trend 
towards more pain, preceding trauma, unconsciousness, and less hypertension and brain 
infarction in ID.  
 
We found 22 SAH patients with dissection between 1998 and 2004 (Table 3). The lesions 
were located mainly in the posterior circulation. Two patients had a bilateral dissection. 
The radiological findings were: fusiform dilatation only (n=11/24, 45.8%), fusiform 
dilatation and stenosis (n=11, 45.8%), or fusiform dilatation with slow filling up with 
contrast agent (n=2, 8.3%). During the same period, there were 67 non-SAH ID or CD 
patients. Thus, in our center, SAH rate of all intracranial dissections was 25%. SAH 
patients were slightly older and more often women. The SAH and non-SAH patients had 
as often headache, which is a typical symptom of SAH. A striking difference between the 
two groups was a clear deterioration in the clinical condition of SAH patients: 80% of 
them were unconscious during hospital stay compared to <8% among non-SAH patients, 
and admission NIHSS and 3-month mRS were higher in the SAH group. All non-SAH 
patients without brain infarction achieved mRS 0-2 by 3 months.  
 
The non-SAH and SAH groups were compared statistically for this thesis (Table 3) 
Severity of stroke (admission NIHSS) was the most important predictor of outcome at 3 
months. Although strokes were more severe and outcome worse in the SAH group, the 
type of CeAD manifestation (non-SAH or SAH) did not have an independent influence on 
3-month mRS.  
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These findings indicate that non-SAH and SAH –type intracranial dissections can be 
distinguished early. Aneurysmatic IDs lead to SAH and have a poor prognosis, whereas 
non-aneurysmatic IADs presenting without SAH are associated with a favorable outcome 
and can be safely treated with anticoagulant therapy. 
 
Table 2. Characteristics of purely intracranial and combined dissections 
 
ID           
n=23
CD‡       
n=57
ID vs.  CD*                       
OR unadjusted (95% CI)
ID vs.  CD*                           
OR adjusted † (95% CI)
Age (years ± SD) 41.5 (10.4) 46.0 (12.0) 1.03 (0.99-1.08) 1.04 (0.99-1.09)





(29.8/70.2) 1.26 (0.45-3.51) 1.05 (0.35-3.18)
ICA/VA (%) 5/18 (21.7/78.3)
17/40 
(29.2/70.8) 0.65 (0.21-2.05) 0.53 (0.16-1.73)
Risk factors
Trauma* 10 (43.5) 16 (28.1) 1.97 (0.72-5.39) 1.80 (0.63-5.14)
Hypertension* 5 (21.7) 25 (43.9) 0.36 (0.12-1.09) 0.39 (0.12-1.31)
Hypercholesterolemia* 15 (65.2) 34 (59.6) 1.27 (0.46-3.48) 1.81 (0.57-5.76)
Smoking* 8 (34.8) 18 (31.6) 1.16 (0.42-3.22) 1.33 (0.45-3.88)
Migraine* 9 (39.1) 15 (26.3) 1.80 (0.65-5.01) 1.49 (0.47-4.71)
Manifestations
Pain 19 (82.6) 38 (66.7) 2.38 (0.71-7.97) 2.21 (0.64-7.61)
Occlusion* 8 (34.8) 28 (49.1) 0.55 (0.20-1.51) 0.52 (0.17-1.54)
Brain infarction 17 (73.9) 50 (87.7) 0.40 (0.12-1.35) 0.28 (0.07-1.10)
Unconscious during hospital stay 3 (13.0) 3 (5.3) 2.70 (0.50-14.50) 1.91 (0.33-11.03)
Median NIHSS at admission if 
infarction (± IQR) 4 (11.5) 4 (6.25) 0.99 (0.92-1.07) 0.99 (0.91-1.06)
mRS 0-1 at 3 months if infarction* 10 (58.8) 29 (58.0) 1.03 (0.34-3.16) 1.31 (0.30-5.67)
mRS 0-2 at 3 months if infarction* 13 (76.5) 37 (74.0) 1.14 (0.32-4.13) 2.80 (0.36-22.10)
Values are n (%) unless otherwise indicated. *Novel unpu blished data. ‡ One patient with both ID and CD is not included in this  column.
† Logist ic regression, adju sted  for age, sex, and  CeAD locat ion (ICA/VA), and mRS additionally adjusted for NIHSS.
ID: pure intracranial dissection; CD: combined dissection (=extracran ial  dissect ion extend ing intracranially); OR: odds  ratio;
CI: confidence interval; SD: standard d eviation ; ICA: internal carotid artery;  VA: vertebral artery;  IQR: interqu artile range; 
NIHSS: National Ins titu tes of Health Stroke Scale; GCS: Glasgow Coma Scale; mRS: modified Rankin Scale
 
 





non-SAH vs . SAH*,                    
OR unadjusted  (95% CI)
non-SAH vs . SAH*,              
OR adjusted  ‡ (95% CI)
Age (years ± SD) 44.8 50.9 0.95 (0.90-0.99) 0.93 (0.88-0.98)
Age range 15-68 32-67
Women/Men (%) 26/55 (32.1/67.9) 11/11 (50/50) 0.47 (0.18-1.23) 0.29 (0.10-0.84)
Pain 58 (71.6) 19 (86.4) 0.40 (0.11-1.48) 0.34 (0.09-1.31)
Unconscious during hospital stay 6 (7.4) 18 (81.8) 0.02 (0.005-0.070) 0.01 (0.002-0.062)
Median NIHSS at admission if 
infarction or SAH (± IQR)
4 (6.75) 12 (21.0) 0.93 (0.88-0.98) 0.91 (0.86-0.97)
Median GCS at admission (± IQR) 15 (0) 11 (9) 1.32 (1.16-1.51) 1.35 (1.17-1.56)
mRS 0-1 at 3 months if infarction* 40 (58.8) 3 (13.6) 9.05 (2.44-33.53) 4.08 (0.86-19.44)
mRS 0-2 at 3 months if infarction* 51 (75.0) 7 (31.8) 6.43 (2.25-18.04) 3.11 (0.67-14.35)
Values are n (%) unless otherwise indicated. Bold font indicates statistical significance. *Novel unpublished data.
‡ Logistic regression, adjusted for age and sex, and mRS additionally adjusted for NIHSS.
SAH: subarachnoid hemorrhage; OR: odds ratio; CI: confidence interval; SD: standard deviation; IQR: interquartile range; 
NIHSS: National Institutes of Health Stroke Scale; GCS: Glasgow Coma Scale; mRS: modified Rankin Scale
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5.2 Clinical features of cervicocerebral artery dissections in a patient 
population from Southern Finland (II)	  
 
 
The characteristics of the patient population of sub-study II are presented in Table 4. A 
total of 301 consecutive CeAD patients with a mean age of 46.6 years were included. Of 
them, 280 (93%) had uniarterial and 21 (7%) had multiple dissection. Intracranial or 
combined dissections constituted 32% of all dissections. However, the location of 
dissection (intra/extracranial) could be defined only for 234 patients of which 95 (41%) 
were IDs or CDs. A clear male preponderance was observed (68%, p<0.001), and men 
were older than women (47.7 vs. 44.0, p=0.006, OR 1.33, 95% CI: 1.09–6.31). More than 
1/3 of the patients had a lifetime history of migraine. MA (63%) was more frequent than 
MO. Current smoking was reported by 39% of men and 29% of women. 
 
5.2.1 Extracranial vs. intracranial and combined dissections 
 
There were very few differences when comparing EADs with IDs and CDs both in 
univariate and multivariate analyses (Table 4). Intracranial and combined dissections 
located more often in vertebrobasilar arteries and they were more often occlusive. Partly 
due to this, VAD led more frequently to brain infarction. The risk factor profile between 
these groups was similar, and the groups had as often cervical pain or headache. The 




a) Characteristics of CeAD patients according to dissection site (extra-/intracranial/undetermined)  
 
EAD ID & CD Undetermined
Number of patients (%) 139 (46)  95 (32) 67 (22)
Age, mean (±SD) 46.0 (10.6) 45.9 (12.3) 48.5 (9.1)
Women/Men (%) 46/93 (33/67) 33/62 (35/65) 18/49 (27/73)
ICAD/VAD (%) 77/62 (55/45) 38/57 (40/60) 42/25 (63/37)
Multiple dissection* 13 (9) 6 (6) 2 (3)
Risk factors
Hypertension* 55 (40) 39 (41) 29 (43)
Hypercholesterolemia* 72 (52) 52 (55) 50 (75)
Smoking* 48 (35) 25 (26) 35 (52)
Migraine*‡ 46/126 (37) 29/87 (33) 22/60 (37)
Previous infection* 24 (17) 12 (13) 14 (21)
Previous trauma* 63 (45) 39 (41) 20 (30)
Brain infarction 87 (63) 74 (78) 60 (90)
Pain* 113 (81) 70 (74) 48 (72)
Occlusion* 32 (23) 41 (43) 60 (90)
Median NIHSS on admission if 
infarction (IQR) 2.5 (6) 3 (5) 4 (7.75)
mRS 0-2 at 3 months if infarction 69/86 (80) 57/75 (76) 43/58 (74)
mRS 0-1 at 3 months if infarction 46/86 (54) 40/75 (53) 27/58 (47)  
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b) Differences between extracranial and intracranial CeAD 
 
 
EAD vs.  ID&CD*                
OR unadjusted  (95% CI)
EAD vs.  ID&CD*             
OR adjusted  (95% CI) †
Age, mean (±SD) 1.00 (0.98-1.02) 1.00 (0.97-1.02)
Women/Men 0.93 (0.54-1.61) 1.00 (0.56-1.76)
ICAD/VAD 1.86 (1.10-3.16) 1.88 (1.10-3.22)
Multiple dissection 1.53 (0.56-4.18) 1.47 (0.53-4.07)
Risk factors
Hypertension 0.94 (0.55-1.60) 0.92 (0.53-1.61)
Hypercholesterolemia 0.89 (0.53-1.50) 0.93 (0.53-1.64)
Smoking 1.48 (0.83-2.63) 1.40 (0.78-2.53)
Migraine‡ 1.13 (0.64-1.97) 1.19 (0.66-2.15)
Previous infection 1.44 (0.68-3.05) 1.33 (0.62-2.85)
Previous trauma 1.19 (0.70-2.02) 1.23 (0.72-2.11)
Brain infarction 0.45 (0.25-0.81) 0.52 (0.27-0.98)
Pain 1.55 (0.83-2.90) 1.73 (0.89-3.33)
Occlusion 0.39 (0.22-0.69) 0.41 (0.23-0.74)
Median NIHSS on admission if 
infarction (IQR) 0.98 (0.94-1.03) 0.96 (0.91-1.01)
mRS 0-2 at 3 months if infarction 1.28 (0.61.2.71) 1.17 (0.39-3.52)
mRS 0-1 at 3 months if infarction 1.01 (0.54-1.87) 0.96 (0.46-2.01)
Values are n (%) unless otherwise indicated. Bold font indicates statistical significance. CeAD: cervicocerebral artery dissection;
EAD: extracranial dissection; ID: pure intracranial dissection; CD: intracranially extending dissection i.e.  'combined' dissection.
Undetermined: Due to occlusion it was uncertain whether the dissection extended intracranially; OR: odds ratio; CI: confidence interval; 
SD: standard deviation; ICAD: internal carotid artery dissection; VAD: vertebrobasilar artery dissection; 
NIHHS: National Institutes of Health Stroke Scale; IQR: interquartile range; mRS: modified Rankin Scale
*Novel unpublished data. ‡Only patients with available migraine data are included.





5.2.2 ICAD vs. VAD 
 
Dissections occurred equally often in ICA (n=157, 52%) and VA (n=144, 48%) (Table 5). 
ICAD patients had two times more frequently previous infections, and ICAD was more 
often extracranial than VAD. VAD led to brain infarction more often, but admission 
NIHSS score was higher among ICAD patients. ICAD patients had a poorer prognosis 
assessed by 3-month mRS.  
 
In multivariable analyses, there was no longer statistically significant difference in 
outcome between ICAD and VAD; outcome was mostly dependent on admission NIHSS. 
Multiple dissections were as frequent between ICAD and VAD. ICAD and VAD groups 
did not differ statistically regarding age, sex, vascular risk factors, migraine, and previous 
trauma. However, in a subgroup analysis, patients with extracranial ICAD were older than 
extracranial VAD patients (48.7 vs. 42.7 years, p=0.001, T-test), but in intracranial 
dissections this was vice versa, although not statistically significant (ICAD 45.1; VAD 






Table 5. Comparison of patients with ICAD and VAD 
 
ICAD     
(n=157, 52%)
VAD    
(n=144, 48%)
ICAD vs. VAD*                 
OR unadjusted  (95% CI)
ICAD vs. VAD*                 
OR adjusted  (95% CI) †
Age, mean (±SD) 47.3 (10.3) 45.8 (11.5) 1.01 (0.99-1.03) 1.02 (1.00-1.05)
Women/Men (%) 43/114 (27/73) 54/90 (37/63) 0.63 (0.39-1.02) 0.64 (0.37-1.14)
EAD/ID&CD (%)* 77/38 (67/33) 62/57 (52/48) 1.86 (1.10-3.16) 1.88 (1.10-3.22)
Multiple dissection* 13 (8) 8 (6) 1.54 (0.62-3.82) 1.39 (0.52-3.69)
Risk factors
Hypertension* 67 (43) 56 (39) 1.17 (0.74-1.85) 1.04 (0.60-1.82)
Hypercholesterolemia* 86 (55) 88 (61) 0.77 (0.49-1.22) 0.57 (0.32-1.01)
Smoking* 61 (39) 47 (33) 1.31 (0.82-2.11) 1.41 (0.79-2.50)
Migraine*‡ 47/138 (34) 50/135 (37) 0.88 (0.54-1.44) 0.63 (0.51-1.70)
Previous infection* 33 (21) 17  (12) 1.99 (1.05-3.75) 1.76 (0.83-3.71)
Previous trauma* 59 (38) 63 (44) 0.77 (0.49-1.23) 0.81 (0.48-1.38)
Brain infarction 99 (63) 122 (85) 0.29 (0.17-0.51) 0.18 (0.09-0.35)
Pain* 112 (71) 119 (83) 0.52 (0.30-0.91) 0.65 (0.34-1.26)
Occlusion* 67 (43) 66 (46) 0.88 (0.56-1.39) 0.50 (0.28-0.92)
Median NIHSS on admission if 
infarction (IQR) 7 (13) 2 (4) 1.20 (1.13-1.27) 1.19 (1.11-1.27)
mRS 0-2 at 3 months if infarction 57/96 (59) 112/123 (91) 0.14 (0.07-0.30) 0.90 (0.26-3.08)
mRS 0-1 at 3 months if infarction 31/96 (32) 82/123 (67) 0.24 (0.14-0.42) 0.55 (0.24-1.24)
Values are n (%) un less otherwise indicated . Bold font indicates stat istical sign ificance.
ICAD: internal carotid artery dissection; VAD: verteb robasilar artery dissection; OR: odds ratio;  SD: s tandard deviation; 
CI: confidence interval; EAD: extracranial dissection;  ID: pure intracranial  dissect ion; NIHHS: National  Insti tutes of Health Stroke Scale;
CD: intracranially extending dissection i.e. 'combined' d issect ion; mRS: modified Rankin Scale
*Novel unpublished data. ‡Only patients with available migraine data are included.





5.2.3 Outcome and recanalization 
 
A favorable outcome (mRS 0-2) at 3 months was observed in 83% of all patients, and 
excellent outcome (mRS 0-1) in 63%. All patients without brain infarction achieved mRS 
0-2. Age had no correlation on favorable outcome in univariate analyses. In univariate 
analyses, poor outcome was associated with ICAD, higher admission NIHSS, brain 
infarction, and occlusion. Total recanalization occurred in 153 patients (54%). Younger 
age was related to recanalization, whereas recanalization occurred less often among 
smokers and those with occlusion. Patients with recanalization had returned to work more 
often by 3 months, whereas recanalization did not associate with better outcome measured 
by mRS. Six (2%) new CeADs were observed during the follow-up (mean 4 years). 
 
Presence or absence of brain infarction and NIHSS at admission remained the strongest 
predictors of outcome in multivariable logistic regression performed for this thesis. Recent 
infections and older age were also associated with worse outcome (Table 6). In addition to 
younger age, non-smoking, and stenosis, previous cervical trauma was related to higher 




Table 6. Predictors of excellent outcome (mRS 0-1) 
mRS 0-1 mRS 2-6 OR (95% CI) OR (95% CI) †
Number of patients (%) 188 (63.3) 109 (36.7)
Age, mean (±SD) 45.4 (10.7) 48.1 (11.1) 0.98 (0.96-0.999) 0.96 (0.92-0.995)
Women/Men (%) 60/128 72/37 0.91 (0.55-1.51) 0.72 (0.29-1.82)
ICA/VA (%) 85/103 (45/55) 68/41 (62/38) 0.50 (0.31-0.81) 0.63 (0.25-1.64)
ED 96 (51.1) 41 (37.6)
ID/CD 59 (31.4) 36 (37.6) 0.028* 0.99 (0.44-2.24)
Undetermined 33 (17.6) 32 (29.4)
Multiple dissection 14 (7.4) 7 (6.4) 1.17 (0.46-3.00) 1.09 (0.26-4.68)
Risk factors
Hypertension 79 (42.0) 41 (37.6) 1.20 (0.74-1.95) 0.82 (0.35-1.89)
Hypercholesterolemia 108 (57.4) 62 (56.9) 1.02 (0.64-1.65) 1.48 (0.63-3.48)
Diabetes 12 (6.4) 5 (4.6) 1.42 (0.49-4.14) 4.10 (0.30-56.38)
Smoking 69 (36.7) 36 (33.0) 1.18 (0.72-1.93) 1.33 (0.54-3.27)
Migraine 66 (35.1) 34 (31.2) 1.11 (0.64-1.84) 0.64 (0.26-1.58)
Previous infection 25/188 (13.3) 24/109 (22.0) 0.54 (0.29-1.01) 0.24 (0.07-0.65)
Previous trauma 87 (46.3) 35 (32.1) 1.82 (1.11-2.98) 1.04 (0.44-2.45)
Brain infarction 75 (60.1) 106 (97.2) 0.04 (0.01-0.14) 0.05 (0.01-0.27)
Pain 151 (80.3) 78 (71.6) 1.62 (0.94-2.81) 0.66 (0.25-1.78)
Occlusion 72 (38.3) 59 (54.1) 0.53 (0.33-0.85) 1.21 (0.48-3.06)
Recanalization 103 (56.9) 50 (50.0) 1.32 (0.81-2.45) 0.93 (0.36-2.37)
Median NIHSS at 
admission if infarction 2 (4) 6 (13) 0.78 (0.72-0.85) 0.78 (0.70-0.87)
Values are n (%) un less otherwise indicated . Bold font indicates stat istical sign ificance.
mRS: modified  Rankin Scale; OR: odds  ratio;  CI: confid ence interval; SD: standard deviation;  
ICAD: internal carotid artery dissection; VAD: verteb robasilar artery dissection; EAD: extracranial dissect ion; 
ID: p ure intracranial dissection; CD: intracranially extending dissection i .e. 'comb ined ' dissection. 
Undetermin ed: Due to occlu sion it  was uncertain whether the dissection  extended  intracran ial ly.
NIHHS: National Insti tutes of Health Stroke Scale;  IQR: interquartile range. * p -value (chi-square)
† Logist ic regression with age, sex, site of dissect ion (ED or ID/CD and  ICA/VA), risk factors , pain, occlusion,




5.4 Vascular risk factors in cervical artery dissection (IV) 
 
We assessed the frequency of vascular risk factors (hypertension, hypercholesterolemia, 
diabetes mellitus, current smoking, and BMI) between 690 (mean age 44.2±9.9 years; 
prospective 232, 34%) Belgian, French, Finnish, or Italian CeAD patients, 556 age-, sex-, 
and country-matched non-CeAD IS patients (44.7±10.5 years), and 1170 healthy referents 
(45.9±8.1 years). About ¾ of the CeAD patients had ischemic stroke or TIA, majority 
(56%) were men, and 65% had ICAD. Most strokes in the non-CeAD IS group were 
cardioembolic (37%) or of undetermined origin (41%).  
 
Compared with healthy controls, CeAD patients had less often hypercholesterolemia (19 
vs. 29%, p<0.0001), and their BMI was lower (24.5 vs. 25.9, p<0.0001). After sensitivity 
analysis excluding participants <35 years, also diabetes was less frequent among CeAD 
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patients (OR 0.43, 95%CI 0.23-0.81, p=0.009). However, CeAD patients had more 
hypertension (25 vs. 19%, p<0.0001). In the secondary analyses, we assessed vascular risk 
factor separately for ICAD/VAD, presence or absence of cerebral ischemia, and 
prospective/retrospective recruitment, all compared with healthy referents, and the results 
remained practically identical. However, in the subgroup of VAD, the association between 
smoking and CeAD became statistically significant (OR 1.39, 95%CI 1.02–1.89, p=0.03). 
 
In comparison with non-CeAD IS patients, all vascular risk factors were less frequent in 
CeAD patients (P for all <0.0001), but in logistic regression adjusted also for all vascular 
risk factors, the difference in diabetes was no longer significant. In secondary analyses, 
country of inclusion or stroke etiology (large-artery atherosclerosis, small-vessel disease, 
and cardioembolism vs. patients other determined cause or undetermined cause) did not 




5.5 Migraine and cervical artery dissection (V) 
 
5.5.1 CeADstroke vs. non-CeAD IS 
 
Migraine was more common in CeADstroke patients (35.7 vs. 27.4%, p=0.003) in a 
multivariate model, adjusted for age, sex, country, prospective/retrospective inclusion, 
hypertension, hypercholesterolemia, smoking, diabetes, BMI, and use of oral 
contraceptives or hormone replacement therapy. The difference was due to MO (20.2 vs. 
11.2%, p<0.001), since the frequencies of MA were not different (13.1 vs. 15.8%, 
p=0.322). 
 
Non-CeAD IS patients with PFO had more migraine, especially MA, compared with other 
IS etiologies (overall migraine 36 vs. 23%, p=0.001; MO 12 vs. 11%, p=0.559; MA 23.6 
vs. 12.4%, p<0.001). When patients with PFO (n=197 non-CeAD IS and 36 CeADstroke 
patients) were excluded, and analyzed were only patients in whom echocardiography was 
done, the difference between CeADstroke and non-CeAD IS groups regarding overall 
migraine became even clearer (37.8 vs. 23.4, p>0.001), but the difference in MA remained 
statistically insignificant (12.2 vs. 12.4%, p=0.938). 
 
5.5.2 CeAD patients with and without migraine 
 
In univariate analysis, CeAD patients with and without migraine differed in 6 aspects. The 
migraineurs were a bit younger and slimmer, they were more often female, had more often 
headache and tinnitus, and slightly less often hypercholesterolemia. After adjustment for 
age, sex, prospective/retrospective inclusion and country of inclusion, only sex and 
frequency of headache remained statistically significant. There was no difference in terms 
of hypertension, diabetes, smoking, admission NIHSS score, prior minor trauma, dissected 
vessel (ICA or VA), vessel patency (occluded or non-occluded), occurrence of ischemia, 
multiple dissections, or dissecting aneurysms. 
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6   DISCUSSION 
 
 
6.1 Intracranial dissections (I) 
 
The sub-studies I and II included both intra- and extracranial dissections. In our sample, 
the proportion of intracranial or intracranially extending dissections of all cervicocerebral 
dissections was approximately 1/3. Our results indicate that if initial brain CT does not 
reveal bleeding, the risk of subsequent SAH from dissection is very low. About ¾ of 
patients with ID or CD occurred without SAH, had favorable prognosis, and could be 
treated with anticoagulants. The rest ¼ had SAH and poorer prognosis. Even if we showed 
anticoagulation in non-SAH patients to be safe, there is, however, no evidence of its 
efficacy or benefits in IADs. 
 
The distinction of ischemic and hemorrhagic dissections has become clearer during the 
past years 7. The favorable outcome in initially unruptured IADs was recently confirmed 
in two relatively large patient series. Among 178 South-Korean patients with intracranial 
unruptured VADs 158, none had SAH during follow-up (mean 46 months). All patients 
with headache only (n=76), and majority (92 out of 102) of those with ischemic symptoms 
achieved mRS 0 to 1.  A Japanese study of 206 IADs in 190 patients by Mizutani et al. 19 
had two groups: unruptured IADs (n=98) and SAH patients (n=108). Only one patient in 
the non-SAH group had bleeding complications during a follow-up of over 3 years. When 
headache preceded onset of SAH, the delay between pain and bleeding was 0 to 3 days in 
96%, and the longest delay was 11 days. The authors state that the repair process after 
artery injury begins shortly after disruption and is completed in about 2 months. In 
agreement with our study, there were more women in the SAH group than in the non-SAH 
group. 
 
Our patient population had similar characteristics with 25 Australian patients with pure 
intracranial dissection 159. The non-SAH patients were younger than those with SAH, and 
ischemic manifestations were most common in the anterior circulation whereas SAH 
occurred mostly in the posterior circulation. Treatment with antiplatelet or anticoagulant 
therapy did not lead to bleeding complications. However, the differences in outcome 
between non-SAH and SAH patients were not statistically significant in that study 159. 
This may in part be due to a small patient number, and different cut-off for good recovery: 
they considered mRS 0 to 3 favorable outcome 159. 
 
 
6.2 Clinical features of cervicocerebral artery dissections in a Finnish patient 
population (II) 
 
Our study sample of 301 patients was a representative population of CeAD patients, since 
it included practically all hospitalized CeAD cases in a large population of 1.5 million 
inhabitants. The mean age was similar to other publications on CeAD 42, and we 
confirmed the previous results about male preponderance in CeAD and that CeAD occurs 
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later in men 65. The sex differences are most likely multifactorial, and may be related to 
different rates of risk factors (hypertension, migraine, trauma) and to hormonal status 
between men and women 160. These factors also change with increasing age 147.   
 
We observed a high frequency of migraine among CeAD patients in sub-study II. This 
finding led to a more detailed study on this subject 86 with a proper control group. 
However, the exact mechanism for the association of CeAD and migraine is not yet clear.  
 
According to Statistics Finland, the average prevalence of adult (15–64 years) smokers in 
Finland from 1994 to 2006 was 27% for men (range: 26–30%) and 20% for women (18–
20%) (http://www.stakes.fi/tilastot/tilastotiedotteet/2011/liitetaulukot/Tr44_11_liitetaulukot.pdf). 
Compared to these figures, CeAD patients were more often smokers, but there was no 
proper control group in the sub-study II.  
 
ICAD patients had less brain infarctions and had more frequently previous infection than 
patients with VAD, although the latter was no longer statistically significant after 
adjustment for age, sex and dissection site. These findings were confirmed later in the 
large CADISP cohort, which partly overlaps with the patient population in sub-study II 161. 
In CADISP 161 and some other publications 63 65, ICAD patients were older than those with 
VAD. In our series this difference was not statistically significant. Interestingly, the 
difference became significant in the subgroup of patients with EAD, while in IADs this 
was vice versa. The difference in age of ICAD vs. VAD between the CADISP study and 
sub-study II can thus be explained by the fact that purely intracranial dissections were 
excluded from CADISP. The CADISP study comparing ICAD and VAD reported that the 
proportion of women is greater in VAD than in ICAD 161. There was a similar trend in the 
sub-study II which did not reach statistical significance. A small series of Lee et al. 63 had 
opposite results, whereas in a Swiss population there was no sex difference between ICAD 
and VAD. A later study from CADISP, reporting sex differences in CeAD, showed that 
after adjustment for age, women no longer had more VAD than men 160. ICAD and VAD 
seem to differ regarding risk factors, and occurrence and severity of stroke. This may in 
part be explained by the differences in embryonic origin of these arteries 161 and the 
mechanical stress to which they are exposed. These factors emphasize the importance of 
taking into account the site of the dissection when analyzing factors related to CeAD. 
 
In our study, patients with extracranial or intracranial and combined dissections had 
similar outcomes. The publications comparing extra- and intracranial dissections in 
Caucasian patients are scarce, and the patients presenting with and without SAH should 
not be regarded as one entity. A recent study from the US 152 reported more frequently (35 
vs. 16%, p=0.018) neurologic deterioration (new TIA/ischemic stroke or death within 1 
year) among patients with intracranial involvement, but only 69 patients were included. Of 
these 69 patients, 23 (33%) were intracranial or extended intracranially. This is in 
agreement with our results (32%). 
 
Previous infection is a known risk factor for worse outcome in brain infarcts 162. The sub-
study II confirmed these results and showed that this is true also in ischemic stroke due to 
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CeAD, even after adjustment for confounding factors. Recanalization had no association 
with outcome measured by mRS, but the patients in whom recanalization occurred, 
returned more often to work by 3 months. Modified Rankin Scale may be too coarse to 
assess subtle differences in recovery. 
 
 
6.3 CADISP study protocol (III) 
 
Several lines of evidence support the idea that genetic risk factors may contribute to 
CeAD, for example autosomal-dominantly inherited dermal connective tissue alterations, 
some cases of familial CeAD, and CeAD occurrence in monogenic connective tissue 
diseases 26. CeAD is a relatively rare disorder, but large patient numbers are needed for 
GWAS analyses. The international CADISP study has allowed establishing the largest 
register of CeAD patients to date. Most of the patients in the clinical part of CADISP are 
European (altogether 18 patients were from Argentina and Turkey), but also a few centers 
from the USA participated in the genetics part. There are major genetic differences 
between people from different countries, also within Europe. This population stratification 
was taken into account using statistical methods. CADISP was the first group that 
performed systematic evaluation of CeAD genetics. CADISP GWAS analysis is 
completed, and it was successful even though the number of patients was lower than what 
is recommended for similar studies, and yielded very interesting results (Debette et al., 
submitted). Previous genetic studies on CeAD have been mostly negative. This is in part 
due to small sample sizes and the fact that they used candidate gene approach which 
requires an a priori hypothesis 26 76. Some findings on previous candidate genes related to 
CeAD 26 could not be confirmed. Initially, healthy controls from the pre-existing 
databases (see Chapter 4.1.2) were planned to be used in the GWAS. However, we were 
able to use the large registry of more than 14000 anonymized control individuals at the 
CNG. 
 
Deciphering genetic secrets of CeAD and examining numerous issues in a large multicenter 
registry does not only serve for shedding light on pathophysiology of CeAD, but gives a 
solid example for future studies targeting at other understudied etiologies of ischemic stroke, 
such as fibromuscular dysplasia and moyamoya disease. 
 
 
6.4 Vascular risk factors (IV) 
 
CeAD patients differ from both non-CeAD IS patients and healthy population in terms of 
vascular risk factors. When assessing the difference between CeAD and referents, it is 
important to know if the control group represents ischemic or healthy people. Regarding 
vascular risk factors, comparing CeAD and non-CeAD IS patients shows that the CeAD 
group is basically healthy with fewer vascular risk factors 105 but it does not reveal 
information that is needed for understanding the pathology in CeAD. Therefore, it is 
important to also have a healthy population for the comparisons.  
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It seems that hypertension is a risk factor for CeAD. It was hypothesized 6 that 
hypertension-induced changes in the arterial wall are more marked in the internal layers. 
This would increase the risk of an internally located dissection, leading to stenosis and 
occlusion more often than a subadventitial tear. It is, however, not known whether the 
mechanism of dissection in patients with hypertension is due to a long-standing elevated 
pressure against the vessel wall or to short, steep daily blood pressure changes 6. It is 
possible that the association is vice versa: the changes in the connective tissue properties 
may lead to elevated blood pressure. Calvet et al. 163 compared 32 CeAD patients with 32 
healthy controls who had similar blood pressures in order to measure carotid wall 
properties. CeAD was associated with increased stiffness of the vessel wall. In sub-study 
IV, the association of hypertension and CeAD was more pronounced in the subgroup of 
ischemic CeAD patients. This is in agreement with the results of Pezzini et al. 6. One 
explanation for this could be higher magnitude of hypertension-induced changes in the 
inner parts of the arterial wall compared to the outer layers – resulting in stenoses and 
occlusions, and thus in infarctions, more often than dissection affecting the outer layers 6. 
Hypertension alone may not, however, have a major role in CeAD pathogenesis since 
frequency of hypertension increases with age but CeAD occurs in younger individuals. 
 
CeAD patients tend to be healthy and often do a lot of sports. This can indirectly be 
confirmed by our finding that their BMI is lower than both non-CeAD IS patients and 
healthy controls. It is also in agreement with the study of Arnold et al. 106 with mean BMI 
22.9 for CeAD patients and 24.5 for healthy controls. The negative association of CeAD 
and hypercholesterolemia is a novel finding. Previous studies have reported similar 
hypercholesterolemia rates for CeAD patients and healthy controls. The results may in 
part depend on the reference values used (for example, hypercholesterolemia was defined 
as >6.2mmol/l in the CADISP study, >5.7 in an earlier Italian study 164, and >5.2 in the 
study of Arnold et al. 106) and the size of study populations. However, the previous and 
current results implicate that elevated cholesterol is not a risk factor for CeAD. Whether it 
is a protecting factor remains to be confirmed. It was discussed 163 that a heterogeneous 
echostructure in the arterial wall is more prone to tear and dissection. With aging and 
atherosclerosis, collagen and elastin cross-links come more abundant and the vessel wall 
becomes more homogenous. Hypercholesterolemia, diabetes, and high BMI could 
accelerate this process 163 165. This could be one explanation why CeAD occurs at a 
younger age. 
 
There was a trend for current smoking being more common among CeAD patients than 
healthy controls in sub-study IV (OR 1.22, 95% CI 0.99–1.50, p=0.07), and the difference 
became statistically significant in the subgroup of VAD. In sub-study II, smokers had a 
lower rate of recanalization, although recanalization had no correlation with outcome, nor 
did smoking itself. Even though the association of smoking and CeAD is not strong, 
smoking might be an additional risk factor for the disease. It is known that smoking is a 
risk factor for impaired wound healing and post-surgical infections 166. The suggested 
mechanisms could also be related to CeAD pathology: detrimental vasoactive effect in 
tissues with fragile blood supply, impaired inflammatory healing response, and alteration 
of collagen metabolism 166. It can be speculated that in non-smokers, small tears in the 
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6.5 Cervical artery dissection and migraine (V) 
 
In the sub-study V we confirmed previous results of migraine being common among 
CeAD patients. In the interpretation of results from various studies of migraine in CeAD, 
the control group used should be taken into account. In the sub-study V, the referents were 
patients with ischemic stroke due to another cause than CeAD. CeAD patients had more 
MO, and the proportion of MA were similar among CeAD and non-CeAD IS patients. 
This is in agreement with previous studies 81 82. It is also known that IS patients have more 
MA than healthy controls 80. Based on these facts, it seems justified to conclude that both 
MO and MA are associated with CeAD patients compared to healthy controls. The few 
studies on this subject support this idea 82 86. We can also state that the non-CeAD IS 
patients are not a neutral control group regarding migraine, and non-CeAD IS patients and 
healthy controls should not be combined in meta-analyses 85. 
 
The frequency of migraine was similar in CeAD patients with and without stroke. This 
indicates that the occurrence of ischemic stroke in CeAD patients is independent of 
migraine history. In a study of Arnold et al. 94, ischemic CeAD patients had less migraine 
than non-ischemic but the difference disappeared in a multivariate analysis.  
 
We did not observe differences in vascular risk factors among CeAD patients with or 
without migraine. It has been debated whether migraineurs from the general population 
have more vascular risk factors than the non-migraineurs or not. A higher risk of ischemic 
events (e.g. coronary heart disease and stroke) and vascular risk factors have been 
associated with MA 167. However, in a study of Pezzini et al. 92, with 981 young stroke 
patients but no healthy controls, patients with MA had less cardiovascular risk factors than 
non-migraineurs. Similarly, according to Schwaiger et al. 168, prevalence, severity, and 5-
year progression of atherosclerosis did not differ significantly between migraineurs and 
nonmigraineurs. As we know from sub-study IV, CeAD patients are generally quite 
healthy and have few vascular risk factors, except for hypertension, and thus statistically 
significant differences among CeAD patients with or without migraine – if they exist - 
would require extremely large patient groups. The only factor that distinguished CeAD 
patients with and without migraine was higher frequency of headache in the acute phase. 
This may be related to sensitization to pain 96. 
 
The association of CeAD and migraine seems clear, although it is not known whether 
there is a causal relationship or both conditions have a common predisposing factor. This 






6.6 Strengths and limitations 
 
The strength of the sub-studies I and II was relatively large patient population and single-
center design. In our region, practically all CeAD and SAH patients are diagnosed and 
treated in the neurological and neurosurgical units of our hospital, which use the same 
electronic healthcare records. Therefore, the patient material is practically population-
based.  Moreover, for the sub-study I, patients from both neurologic and neurosurgical 
units were recruited.  
 
The strengths of the CADISP study are i) large sample size, made possible by 
international multicenter recruitment, ii) collection of a homogenous patient population by 
using strict inclusion and exclusion criteria, iii) use of a detailed, standardized 
questionnaire, iv) two control groups: non-CeAD IS patients from the same centers as 
CeAD patients, and healthy controls, and v) for the genetic part, systematic search for 
polymorphisms associated with CeAD, as well as using candidate gene approach, which 
allows to confirm previous studies. 
 
The limitations of the study are as follows. Since the patient records of SAH patients were 
checked retrospectively and many of them died, the data concerning risk factors and 
symptoms could not be assessed reliably. The sub-study II lacked a control group, and 
comparisons of CeAD patients and healthy population regarding vascular risk factors and 
migraine were done indirectly. Despite using the standardized questionnaire in CADISP, 
we had no data on frequency of migraine in non-Finnish healthy controls. The recruitment 
of healthy controls was done as part of CADISP in one center only, and for many centers 
healthy controls were not available at all. The collection of data for healthy controls was 
heterogeneous across countries: for French/Belgian and Italian healthy controls, weight 
and height were measured, whereas for others the data was based on self-reported values. 
In addition, for the Finnish healthy controls, blood pressure or cholesterol levels were not 
measured during recruitment process. CeAD patients were recruited in neurological 
departments. Therefore, some patients with very mild or no symptoms were likely to be 
















7    CONCLUSIONS  
 
Dissections in intracranial parts of ICA and VA or basilar artery can be safely treated with 
anticoagulants if there is no evidence of acute SAH at admission. These patients have a 
favorable prognosis (I). CeAD occurs predominantly in men. It is possibly associated with 
smoking and migraine, especially migraine with aura. Older age, stroke severity, and 
recent infection may predict poorer outcome (II). 
 
In relatively rare diseases such as CeAD, multicenter registries are an important way to 
collect reliable information (III). CeAD patients have less vascular risk factors than 
patients with ischemic stroke due to a cause other than CeAD. Compared to healthy 
controls, CeAD patients have more hypertension but less hypercholesterolemia and 
overweight (IV). 
 
CeAD patients have more migraine without aura compared to non-CeAD IS patients. 
CeAD patients with migraine are more often women and have more often headache as 
CeAD symptom than patients without migraine (V). 
 
The increase in the knowledge about CeAD as one of the most important single etiologies 
of ischemic stroke in young adults has been rapid in the past years. Yet, many dissections 
remain undiagnosed. Studies on the field thus concentrate on characteristics of diagnosed 
CeAD patients, while the fraction of undiagnosed CeADs with mild symptoms is 
unknown. The results may not be directly applicable to all CeAD cases, but they can be 
regarded valid for the patient population that is diagnosed and treated in our hospitals. 
Fortunately, CeAD without ischemia is usually a benign disease with a relatively low rate 
of symptomatic recurrences.  
 
In this thesis, several potential risk factors for CeAD were examined. In contrast with 
individuals having treatable risk factors such as overweight, diabetes, hypertension, 
elevated cholesterol values, and a physically inactive life style that are at risk of other 
cerebrovascular diseases, CeAD patients typically have no significant comorbidities. 
Migraine and hypertension were common among CeAD patients, but for the present we do 
not know the pathogenesis of CeAD sufficiently, and we have no primary prevention for 
the disease. To reach these goals, studies like this one are much needed, providing 
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